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SUMMARY
Cardiovascular disease (CVD) is the leading cause of death across the globe
claiming 17.3 million lives every year. According to the most recent report from the
American Heart Association (AHA), heart disease strikes a person every 42 seconds
in the United States and the direct and indirect costs of heart disease total more than
$316.6 billion. Hence, it is of no surprise that AHA recommends home monitoring of
patients with heart failure (HF) and other heart disorders. Recently, many devices
have been proposed for monitoring hemodynamics at home. However, most if not all
of these are obtrusive and require trained experts to operate them. Moreover, for a
thorough assessment of cardiovascular function, it is important to monitor respiratory
parameters as well since both systems are functionally interconnected with each other
and cardiac diseases affect the respiratory system and vice versa.
This research focused on a variety of sensors to estimate mechanical parameters
related to respiration and cardiovascular health. Specifically, the work explored the
use of non-contact sensors for detection of sleep apnea, a pause in breathing during
sleep, and wearable and unobtrusive sensors for measuring body vibrations caused by
flow of blood into the vasculature.
Despite the presence of different types of sensors for sleep apnea monitoring, there
are still stringent requirements on position and placement of the sensors for the whole
night recording. Some of the sensors are a source of discomfort to the patients as they
require contact with the skin and also are a cause of concern for hygiene. Sensors
which do not require direct skin contact—such as radar based measurement of chest
wall movement, and microphones to record snoring and breathing sounds—would be
preferable, but require advanced processing methods to extract actionable information
xvi
regarding sleep quality. In this work, such processing methods including feature
extraction and machine learning algorithms were developed and verified.
In parallel to the efforts focused on non-contact chest wall movement analysis for
sleep apnea detection, this work investigated the analysis and interpretation of car-
diogenic body vibrations caused by flow of blood into the vasculature. These minute
body vibrations are called ballistocardiogram (BCG) signals and the phenomenon is
termed as ballistocardiography (BCG). Specifically, this work delved deep into the
hemodynamic origins of these vibrations and used feature based methods and system
identification techniques to associate the BCG vibrations to more known phenomenon
related to flow and pressure of blood. A novel system was presented to estimate stroke
volume changes from the BCG signals. Further, the effect of posture on these vibra-
tions from wearable and / or unobtrusive sensors and how these affect the accuracy
of measured parameters was also investigated. Features of the signal specific to non-
ideal posture were identified, such that changes due to underlying patho-physiology
could be separated in future studies from changes related to posture.
The body vibrations are sensitive to motion artifacts and any movement on the
part of the subject can compromise the signal-to-noise ratio (SNR) of the measured
signal from any type of sensor. Novel algorithms were presented in this work to remove
walking related motion artifacts from the BCG signals measured using accelerometers.
These methods open the door for robust estimation of systolic time intervals from the
BCG during walking and can help in understanding the changes in cardiovascular
physiology in response to stressors caused by exercise or simple activities.
The algorithms and methods presented in this work for respiratory and cardiogenic
vibrations can be used to monitor cardiovascular patients at home using inexpensive
and compact sensors. This would decrease the number of re-hospitalizations each




Cardiovascular and respiratory diseases are leading contributors of health problems in
the world. Cardiovascular disease (CVD) alone accounted for 25% of the total deaths
in the United States last year and heart-related healthcare expenditures totaled more
than $300B annually [64]. These numbers are expected to rise in the coming decades
and by 2030, 40% of the US population is predicted to be afflicted by some form of
CVD. This will lead to a further increase in the sky-rocketing costs of healthcare and
other health-related expenditures. At the same time there is an expected shortage of
healthcare providers per patient in the coming ten years [17]. This imminent problem
of mismatch between the number of patients and healthcare resources available per
patient can be addressed by inexpensive devices that enable assessment of patient
health in home settings and can be operated without the supervision of trained clini-
cians. However, most of the devices that exist today lack the capabilities to measure
a wide variety of physiological parameters required for assessment of respiratory and
cardiac function.
The recent advances in semiconductor fabrication processes and increase in the
number of computing tools has resulted in the advent of low-cost miniature sensors
that can be embedded into novel and unobtrusive wearable technologies or used with
existing devices that can be easily integrated into the infrastructure of a patient’s
home. These novel technologies, which include radars, miniature acoustic sensors,
accelerometers, pressure mats and other electro-mechanical sensors, can increase the
span of physiological parameters that can be measured via home monitoring without
causing any significant change or hindrance in a patient’s daily routine or activities.
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Home monitoring of CVD requires the sensing of both cardiovascualr and respi-
ratory health parameters, as these two systems are intertwined with each other. The
human cardiovascular system receives oxygenated blood from the lungs in the left
atrium while simultaneously receiving de-oxygenated blood in the right atrium from
the vessels [72]. The oxygenated blood is then pumped into the aorta through left
ventricle while the de-oxygenated blood is sent to the lungs through right ventricle
[72]. Hence, both the cardiovascular and respiratory system work in conjunction with
each other. Any issue that affects the respiratory system can also impact the cardio-
vascular system and, conversely, early symptoms of many cardiovascular health issues
also manifest in the respiratory system.
One such respiratory disorder that affects heart health is sleep apnea [92], which
is caused by involuntary cessation of breathing during sleep [8]. Approximately 92%
of women and 83% of men with sleep apnea remain undiagnosed imposing a burden
of $3.4B on the annual medical costs [77]. If left untreated, sleep apnea is linked to a
growing number of cardiovascular health problems that include high blood pressure,
diabetes, irregular heart rate and depression [63]. Moreover, recent studies have shown
that people with sleep apnea are at higher risk of developing coronary heart disease
and heart failure (HF) [38]. Accordingly, there is a growing need to have monitoring
systems which utilize minimally invasive and unobtrusive sensors for early detection
of sleep apnea.
Such early detection of sleep apnea can potentially reduce the incidence of down-
stream cardiovascular disorders including HF—a progressive condition in which the
heart cannot supply sufficient blood to meet the demand of the tissues and organs
[53]. In the early stages of HF, the contracting muscles of the heart get bigger and the
blood is pumped more strongly to meet the demand of the body. The body also tries
to compensate by diverting blood away from less important tissues. However, as the
HF condition worsens, there comes a time when the body and heart cannot keep up
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with each other. The compensatory methods of the body are the reasons people do
not notice their condition until the decline of the heart reaches its later stages. HF is
an archetypal example of a cardiovascular disorder that requires improved continuous
monitoring [19].
For both sleep apnea detection and HF monitoring, the major technological ob-
stacle is the inability to monitor the mechanical parameters of physiological function
outside of clinical settings. Home monitoring systems for both sleep apnea and CVD
include sensing modalities such as electrocardiography (ECG), nasal air flow sensors,
impedance cardiography (ICG), respiratory plethysmography and pulse-oximetry. Al-
though these sensors can provide accurate information regarding respiratory and car-
diovascular function, they are far from unobtrusive and require trained personnel for
operation. For example, ICG requires placement of eight electrodes on the neck and
thorax by a trained professional [43]. Patient discomfort and thus low acceptance
of the sensing modalities can also pose challenges: for example, wearing the nasal
air flow and respiratory plethysmography sensors can certainly cause discomfort and
possibly even vary the sleeping behavior of the subject.
The aim of this research is to not only explore signals from existing measuring
modalities, but also look for new sensors for measuring physiological parameters for
monitoring of sleep apnea and cardiovascular health. In this context, we aim to com-
bine the respiratory effort signals from a non-contact impulse-radio ultra-wide band
(IR-UWB) radar and acoustic signals from a microphone for screening and detection
of sleep apnea. Similarly, for HF we aim to investigate ballistocardiogram (BCG),
the measurement of reactionary forces of the body caused by ejection of blood into
the vasculature [43]. BCG is not a new methodology. In fact, it was first discovered
in the late 19th century by J. W. Gordon who observed fluctuation in the weighing




























Figure 1: The organization of research work presented in this thesis.
his colleagues showed that BCG can be used for detection of cardiovascular anoma-
lies [95]. However, at that time, BCG measurement required heavy and cumbersome
instrumentation; on the other hand, there were rapid improvements in other cardio-
vascular measurement instruments such as ECG and imaging technologies. Hence,
the interest in BCG slowly waned as these other devices became commonplace. Re-
cent advances in sensing technologies have allowed for unobtrusive and even wearable
BCG measurement instrumentation to be developed over the past decade, and this
has in turn revived the interest in BCG as a tool for physiological monitoring. These
instrumentation advances are also bolstered by the fact that research in both the en-
gineering and clinical communities has demonstrated the potential clinical relevance
of BCG signal features.
Thus, the objectives of proposed research are two-fold: (1) to design signal pro-
cessing techniques and algorithms for detection of sleep apnea using a combination
of non-contact under-the-mattress IR-UWB radar and a microphone placed on the
side-table, and (2) to develop methods for accurate estimation of various cardiac pa-
rameters from the BCG signal obtained from variety of sensors and investigate the
physiological origins of the BCG. The step-by-step flow of research work in this thesis
is presented in Fig. 1.
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1.1 Major Contributions of the Study
There has been a considerable amount of work done on the use of non-contact sensors
and BCG for measuring mechanical parameters of physiological function. However,
there are important gaps in the existing framework of these methodologies that need
to be bridged in order to use them for continuous home monitoring of respiratory and
cardiovascular health.
The existing research has already explored the use of IR-UWB radars and mi-
crophone based snore analysis for the detection of sleep apnea. However, a major
limitation in this field has been the stringent constraints on the placement of sen-
sors during the recording process. Moreover, a combined system composed of both
IR-UWB radar and microphone has also not been investigated. Can a radar alone
provide excellent accuracy in detection of sleep apnea? Will adding other non-contact
sensors such as a microphone cause an improvement in the overall performance of the
system? Can multiple sensors provide relaxation in strict requirements placed on the
position of a single sensor? In this work we try to address these important questions.
Similarly, BCG has shown to be able to provide features that can be used for
cardiovascular assessment. But whilst the BCG provides parameters based on body
vibrations, clinicians and physicians are more interested in existing hemodynamic
parameters describing the cardiovascular function in terms of flow and pressure of
blood. Moreover, these body vibrations are affected by change in posture and move-
ment. This work focuses on expanding the number of parameters estimated from
the BCG for cardiovascular monitoring while exploring the relationship of BCG with
existing hemodynamic phenomenon and also on expressing these estimated BCG pa-
rameters in terms familiar to clinicians and cardiac experts. Moreover, methods are
presented to overcome the changes in the BCG signal induced by posture related
changes and walking to improve the accuracy of BCG-derived parameters in these
phases.
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Thus, the major contributions of this work, and their potential impact in the field
of research and more broadly to society, are given below:
1. Designed algorithms for extraction of novel features from respiratory signal
measured using an IR-UWB radar. Combining these with features from non-
contact microphone sensors can lead to the design of a user-friendly and robust
system for automated detection of sleep apnea in home settings.
2. Demonstrated using system identification techniques that a linear relationship
in mapping BCG signals to ICG-based blood flow signals was preserved during
physiological perturbations, and significantly better than the corresponding re-
lationship between BCG and arterial blood pressure (ABP) signals. Converting
BCG signals to corresponding ICG signals can broaden the range of hemody-
namic features estimated from the BCG and also provide clinically relevant
insight into the BCG signal’s origin.
3. Designed and validated robust data driven algorithms for estimating systolic
time intervals (STIs) from BCG signals during walking at light to moderate
speeds and in non-ideal postural conditions. Specifically, the BCG data during
walking is either completely ignored due to very low signal-to-noise ratio (SNR)
or limited to heart rate estimation only. These algorithms can, for the first
time, capture changes in cardiovascular physiology during exercise or movement
intervals using BCG signals.
4. Demonstrated that wearable ECG / BCG based measures of pre-ejection pe-
riod (PEP) changes in response to the six minute walk test were significantly
(p < 0.05) lower for patients with decompensated heart failure (New York
Heart Association (NYHA) Class IV) as compared to compensated heart fail-
ure (NYHA Class I-II). Knowing that PEP changes in response to exercise
captured by a wearable patch can separate compensated from decompensated
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HF patients and lead to an automated wearable system to potentially predict
decompensation beforehand, allowing physicians to intervene accordingly.
1.2 Thesis Organization
The rest of the thesis is organized as follows: The previous work in both sleep apnea
detection and BCG based cardiovascular monitoring are reviewed in Chapter II. The
chapter also discusses important nomenclature for the BCG signals measured with
different sensors and from different locations on the body. Chapter III discusses the
detection of sleep apnea disorder with non-contact sensors. Novel algorithms are
presented for extraction of features from the IR-UWB radar signal along with the
effect of adding a microphone sensor on the overall performance of the system.
The hemodynamic origins of BCG are investigated in Chapter IV by exploring
the feature based relationship of BCG with pressure and flow of blood. Moreover,
the chapter also outlines a system identification approach for converting the BCG
waveforms to equivalent ICG waveforms which leads to estimation of stroke volume.
The method presented in Chapter IV can be extended for monitoring stroke volume
changes at home.
The effect of posture on BCG signals is analyzed in Chapter V. Two different types
of sensors are considered in this work. The first half of the Chapter focuses on the
BCG signals from a modified-weighing scale sensor while the later later half analyzes
the BCG signals from a wearable sensor. A novel method is presented for estimation
of cardiovascular parameters in sitting postures using the modified-weighing scale.
Similarly, novel features are extracted from the wearable BCG to improve the accuracy
of cardiovascular parameters during different standing postures.
Algorithms are presented to estimate cardiac parameters from the BCG during
walking in Chapter VI. As briefly mentioned earlier, the body vibrations measured
using any BCG sensor are extremely sensitive to motion. Almost all of the current
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research on the BCG based physiological monitoring focuses on the signals measured
during the resting state while ignoring the signals in the movement related periods.
Thus, data during these periods which has low SNR but contains extremely useful
information about changes in cardiovascular changes in response to simple activities
such as walking is discarded. In Chapter VI, we focus on removal of walking induced
noise by implementing empirical mode decomposition (EMD) algorithm from the
BCG signals measured with a wearable patch. The chapter lays the foundation for
future work on walking BCG signals and identifies how walking speed contributes
towards a decrease in time resolution of the estimates obtained from the de-noised
BCG signals.
Chapter VII discusses the work on monitoring of HF patients using BCG. The
work involves data from a pool of HF subjects at different stages of the disorder.
A novel method is presented that estimates PEP from wearable BCG signals before
and after a 6-minute walk test, commonly used in clinics for evaluation of an HF
patient, and quantifies the change in PEP that occurs due to the walking exercise.
Initial results show that wearable BCG can be used for assessing the condition of HF
patients and also indicate that features from the BCG can be used for prognosis of





Apnea is a Greek word that means ‘without breath’. Sleep apnea involves cessation
of breathing for 10 or more seconds [8]. There are three main types of apneas: (1)
obstructive sleep apnea (2) central sleep apnea, and (3) mixed sleep apnea. The
obstructive sleep apneas, with an estimated prevalence of 5-15% among adults [77],
are the most common occurrence of sleep related breathing disorders (SBD) in which
muscles such as soft palate and tongue relax and block the upper airway during sleep.
This causes a temporary pause in breathing. A 90% or greater drop in breathing
amplitude is termed as obstructive apnea (OA) while a 30% or greater decrease is
referred to as an obstructive hypopnea (OH) event [8]. Thus, obstructive apneas are
caused by complete obstruction of upper airway while hypopneas are due to partial
obstruction. In central apneas, the brain fails to send signals to breathing muscles
and an interruption in breathing occurs without narrowing of upper airway. The met-
rics to quantify the severity of the disorder includes Apnea-Hypopnea Index (AHI),
which is the number of apnea and hypopnea events in one hour [8]. The standard
approach of diagnosing sleep apnea is polysomnography (PSG), which monitors sleep
and respiration by measuring a number of physiological parameters including ECG,
blood oxygen saturation (SpO2), chest effort signals and nasal pressure. However,
PSG is an expensive procedure and requires sleeping in well equipped and technician
attended laboratories. However a large number of sensors are attached to body at
various locations that may cause discomfort and also vary the sleeping behavior for
that particular night.
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Research on monitoring and detection of sleep apnea at home can be divided into
three main categories based on physiological signals under consideration:
2.1.1 Heart Rate Variability (HRV)
The onset of sleep apneas are accompanied by decrease in heart rate (bradycardia) and
the culmination involves elevated heart rate (tachycardia). HRV is the most common
and highly used feature in automated detection of sleep apnea outside clinical settings.
It involves calculation of R-R time intervals from ECG signal [20, 106]. Statistical
features are then derived from time and frequency domain representation of the R-
R intervals [20] followed by application of classification algorithms. Research has
shown that HRV based features can accurately detect sleep apena events. Along
with ECG derived features, authors in [20] have also used features from respiration
signals estimated from the raw ECG data. The ECG signal, obtained from electrodes
attached to chest, contain the respiratory component which can be filtered out and
features can be derived from it to assist in HRV based sleep apnea detection.
2.1.2 Nocturnal Sound Analysis
Loud snoring has long been associated with monitoring of sleep apnea [74]. Vibrations
of soft-palate and uvula produce snoring sounds. Since obstructive sleep apnea is
caused by blocking of the upper airway due to tongue and soft palate, this narrowing
of the upper airway causes a change in the properties of the snores. Many researchers
have analyzed snoring sounds to differentiate between normal and apneic subjects.
The snores from apnea patients exhibit different acoustic attributes than those from
healthy subjects. The most prominent of these features include pitch of the snoring
sound [1, 2, 7], spectral features [69, 87, 91], mel cepstral coefficients (MFCCs) [2, 7]
and formant frequencies [68, 89, 90].
In order to record snores, a contact microphone, placed on neck, has been used
in [91] while a non-contact microphone has been utilized in [69]. The non-contact
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microphone needs to be placed at an optimal position to avoid loss in efficiency of
the system [74].
2.1.3 Respiratory Signals
Respiratory signals, more commonly known as ‘Respiratory Effort’ signals, derived
from chest abdominal straps and nasal sensors, have been used in [67, 101] to success-
fully detect apnea events. Any change in the air volume in the lungs is measured by
the change in cross-sectional area of ribs and abdomen. Microwave radars (doppler
and IR-UWB) have gained a lot of popularity in measuring vital signs [56, 70, 94].
The radar signal, if directed towards a human torso, is reflected from the skin in-
terface and contains information about respiration [70]. Thus any change in chest
displacement, caused by apnea or any other respiratory disorder, will manifest itself
in the reflected signal. The main differences between the doppler and the IR-UWB
radars are the bandwidth, power, and the band of operation. The IR-UWB radar
signal can be spread throughout the 3 to 10 gigahertz band [15], which spans many
other licensed and unlicensed bands. The doppler radar must be used in either a
licensed band or an ISM (industrial, scientific and medical) band, and makes more
interference on other devices because of its more narrow bandwidth and also it is more
vulnerable to the interference from these other devices. Because of its extremely wide
bandwidth, the IR-UWB radar can be operated at a much lower average power than
the doppler radar, for the same SNR in the radar receiver, and it has higher time
resolution which translates to more sensitivity to small periodic movements of the
reflecting surfaces. A doppler radar has been used in [57] to detect different types
of breathing disorders that include apneas. Similarly two microwave radars are used
in [49] to detect sleep apneas. Doppler radar is used in [21, 107], in a device placed
on the bedside table named ‘Sleepminder’, developed by Biancamed for detection of
sleep and wake patterns along with apnea events.
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As discussed earlier, even though there are many portable devices for home mon-
itoring of the sleep apnea disorder, most of these still require contact with the skin
and thus may cause discomfort and skin irritation. On the other hand, the devices
like microphone and radars do not cause any skin contact but they still impose strict
constraints on placement of the sensors. The work in Chapter IV will try to address
these constraints by exploring combination of more than one measurement modality.
2.2 Ballistocardiogram
BCG is the measure of the whole body motion caused by the ejection of blood into
the vessels [37]. It was first discovered by J. W. Gordon in 1877 who observed a
fluctuation in the weighing scale needle due to heart beat [37] and proposed that
change in the weighing scale measurement is caused by ejection of blood. In 1940,
I. Starr [95] showed that BCG can be used to assess cardiac anomalies. However,
due to presence and advent of electrical and electromagnetic heart monitoring and
imaging techniques, the interest in BCG related sensors vanished. As the 20th century
approached its conclusion, the rapid growth in population and a resultant mismatch in
health resources triggered the need for home based unsupervised patient monitoring.
The concurrent developments in semiconductor and fabrication technologies ushered
an era of extremely small and low-cost sensors which can be integrated into existing
devices. In the last few decades, researchers have measured BCG using instrumented
chairs and beds [5, 11, 24, 60], weighing scales [36, 45], accelerometers [102], pressure
sensors [83] and force plates [98].
2.2.1 Cardiogenic Vibrations from Different Sensors
The choice and type of sensor and its placement on the human body dictates the
type of vibrations picked by it. The signals from a weighing scale, which can be
modeled as a second order mechanical system governed by Hook’s law [74], are directly
proportional to displacement [43]. On the other hand, the signals from a wearable
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accelerometer sensor [43], when placed anywhere, are acceleration measurements of
the surface of the skin. The position of the wearable sensor on the body such as
an accelerometer also affects the range of signals captured by it. For instance, if a
tri-axial accelerometer is placed on the sternum or anywhere in the chest region, the
vibrations in the head-to-foot direction (along the body) are low frequency signals
and contain information about hemodynamics. However, the vibrations in the dorso-
ventral direction (axis of the accelerometer perpendicular to the surface of the body)
not only contain vibrations due to flow of blood but these also have high frequency
components which are caused by opening and closure of the heart valves [13]. These
high frequency vibrations from the chest are given a specific name in literature and are
called seismocardiogram (SCG). It has been shown in [13] that a tri-axis accelerometer
can detect the first and the second heart sounds from the dorso-ventral axis signal if
placed on the sternum. It is important to mention here that the term SCG is only
used for dorso-ventral vibrations from the chest region. If the accelerometer sensor is
placed on any other location in the body, these vibrations will not be termed as SCG.
In fact, vibrations from other body locations will not contain heart sound components.
Hence, wearable ballistocardiography (W-BCG), a more generic term, is used in this
thesis for all types of signals measured from a wearable tri-axial accelerometer sensor
placed any where on the body including the sternum.
2.2.2 BCG based Cardiovascular Health Assessment
Since the BCG measurements are due to the flow of blood, these can provide reliable
estimates for hemodynamic assessment and can yield insight into the mechanical
health of the heart. The mechanical health refers to amount of time a human heart
spends during different phases of a cardiac cycle as shown in Fig. 2. The cardiac cycle
is composed of four distinct phases—isovolumic contraction, rapid ejection, isovolumic



























Left ventricle ejection time (LVET)
Figure 2: Cardiac cycle showing different systolic time intervals.
these phases can provide great insight into the health and function of a person’s
cardiovascular and autonomic nervous systems [59]. The period of the isovolumic
contraction, also known as PEP, is the time between the electrical excitation of the
ventricular cardiomyocytes and the ensuing opening of the aortic valve. PEP is a
surrogate non-invasive measure of myocardial contractility [58]. The period of the
systolic ejection, also know as left ventricular ejection time (LVET), is the time taken
for the blood to be ejected from the ventricles, started by the aortic valve opening and
ended by its closing. PEP and LVET are called STIs. The sum of PEP and LVET is
the total time the heart spends in systole (ejection) as compared to diastole (filling)
and is an important parameter for monitoring of patients with heart disorders [19].
In the coming decades, the number of patients with heart disorders is expected
to increase dramatically [64] as is the corresponding cost of healthcare; accordingly,
there is an impending need for creating new, inexpensive and ubiquitous technologies
for continuously monitoring cardiovascular health parameters, such as STIs. Unfortu-


















Figure 3: Important features and points on the ECG and BCG signals. The R-peaks
in the ECG signal are used to segment the signals from the BCG sensors. The BCG
signal shown in the figure is from a modified weighing scale sensor. The W-BCG
signal shown is from the dorso-ventral axis of an accelerometer placed on the chest.
The highest peak in the BCG signal is called the J-peak. Similarly, the features on
the dorso-ventral acceleration signal are the AO- and AC-points. The portions of
the BCG signals between two ECG R-peaks are extracted and averaged to assist in
feature extraction and noise reduction.
devices which typically focus on electrical measurements only (e.g. ECG based Holter
monitors or patches [30]). Recent research has demonstrated that BCG derived fea-
tures contain important information regarding myocardial contractility [29]. Authors
in [28] showed that the R-J interval (shown in Fig. 3)—defined as the time interval
between the ECG R-peak and the maximum peak of BCG signal, the J peak—is
highly correlated with PEP, and thus a surrogate measure of cardiac contractility
[72]. Similarly, the accelerometer signal along the dorso-ventral axis, as shown in Fig.
3, contains features corresponding to opening and closure of aortic valves, i.e., the
AO- and AC-points labeled in Fig. 3. The time difference between the ECG R-peak
and the AO-point on the signal gives an estimate of the PEP and the time interval
between the AO- and AC-points gives LVET. The choice of AO- and AC-points varies
in existing literature. Some authors prefer the global maximas in the first and second
half of the trace as AC- and AO-points while some choose minimas as features. In
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Fig. 3, the AO- and AC-points are illustrated as the minimas in the first and second
half of the dorso-ventral signal between two ECG R-peaks.
2.2.3 Processing of BCG
The common processing of BCG signals from all types of sensors usually involve
simultaneous measurement of the ECG which helps in the segmentation of the BCG
signals as shown in Fig. 3. The BCG signal between two ECG R-peaks is extracted
and the BCG traces within some time interval or a specific number of BCG traces
are averaged to reduce noise and get an averaged trace called ensemble average and
the whole process is called ensemble averaging [93]. The length of this BCG trace is
equal to the R-R interval duration obtained from the ECG. If other reference signals,
such as ICG or ABP are measured along with the ECG and BCG in a project, then
those undergo similar segmentation.
Most of the current research on the BCG focuses on features in the form of timing
intervals for cardiovascular monitoring. There is a compelling need to analyze how
different postures and simple activities such as walking affect these features. More-
over, clinicians are more concerned with parameters related to pressure and flow of
blood as compared to simple timing based measurements from vibrations. Hence, it
is important to deeply investigate the BCG relationship with pressure and flow of




SLEEP APNEA DETECTION WITH NON-CONTACT
SENSORS
3.1 Introduction
Sleep apnea, as discussed earlier, is a respiratory disorder that can cause different
health and behavioral problems and also effects activities of daily living. It’s diagnosis
requires overnight monitoring in well equipped laboratories under the supervision of
sleep specialists or technicians. The home monitoring of this disorder can be done
with different devices most of which utilize contact sensors which may be a source of
nuisance for the patient.
The objective of this study was to use non-contact sensors such as a radar and a
microphone, placed at sub-optimal locations, and analyze if the features from both
the modalities can be combined to give a better performance in classification between
epochs belonging to normal sleep and those that contain an apnea or hypopnea event
in them. The following sections explain the experimental setup, data processing steps
and feature extraction methods used for both the IR-UWB radar and microphone
data. Later we discuss the classification results from radar only features and whether
including microphone based features can provide an improvement in classification
accuracy.
3.1.1 Measurement Setup & Protocol
The data for the project was collected at a sleep research laboratory (Neurotrials
Research Inc.) under a protocol approved by the Georgia Institute of Technology In-







































Figure 4: (a) Block diagram of the setup. (b) The IR-UWB radar signal in one epoch
of 60-sec duration. (c) The microphone signal in 60-sec epoch. The snores in the
signal are shown with a black dash on the top.
on the side-table adjacent to bed while an IR-UWB radar system, developed by Sen-
siotec Inc. [32] was placed under the mattress. The radar transmitted pulses were
13 ns long, centered at 4.2 GHz. At the receiver, the reflected signal was time-gated
and down-converted to baseband and then hardware-filtered into a respiration band
(low pass, cut-off frequency 0.7 Hz) and heart band (cut-off frequencies: 0.5 - 6 Hz),
respectively. Only the respiration band was considered in this research. Next, the
outputs of each filter band were sampled at 128 Hz and quantized for subsequent
digital signal processing. The microphone signal was sampled at 44.1 kHz, band-
pass filtered (cut-off frequencies: 70 - 2000Hz) and downsampled by a factor of 4 to
provide ease in processing and feature extraction. The PSG data was also collected
simultaneously. The data from the IR-UWB radar and the PSG data were both time
stamped. A specialist from Neurotrials scored the PSG and marked all the normal
and apnea epochs. A block diagram of the setup is shown in Fig. 4 (a).
3.1.2 Pre-processing of Data and Motion Detection
In order to facilitate the extraction of features, the quantization noise in time domain
respiratory signal was removed by filtering twice with a 20 tap triangular filter. To
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avoid changing the amplitude and shape of the signal, only the central tap was as-
signed a weight of two while the remaining taps had unity weights. An example of the
respiration signal produced by the IR-UWB radar after the application of triangular
filter is the blue oscillating waveform shown in Fig. 4 (b). The radar signal was very
sensitive to motion and showed clipping to the ADC maximum and minimum levels
whenever the subject made large muscle movements. The part of the IR-UWB data
that contained motion artifacts was detected and removed. All the maximas and min-
imas in the input time domain signal were compared against pre-defined thresholds.
If a maxima was above the upper threshold, then the portion of the signal containing
that maxima along with one previous and one next maxima were labeled as motion
corrupted. A similar approach was used for a minima that was found below the lower
threshold. The reason for including one previous and one next maxima or minima
was to make sure that the complete portion encompassing motion was removed. The
clean signal that fell between the two motion corrupted parts was standardized by
calculating the z-score of each data point in that portion. The z-score was calcu-
lated by subtracting the mean and dividing by standard deviation of the signal. The
reason for separate standardization of data that were separated by motion corrupted
regions was to avoid error in feature extraction stage as the radar signal’s amplitude
was different for different postures and varied across population, especially across
genders.
The microphone signal was manually analyzed to label snoring events. The fea-
tures from the microphone data were later extracted from these manually detected
snores. It is important to mention here that since the data set included only 4 sub-
jects, an automated snore detector was not developed for this study.
19
3.1.3 Extraction of Normal & Apnea Epochs
Epochs of 60 second duration, that included the marked apnea event, were extracted
from the IR-UWB radar data and microphone data. More specifically, the 60 seconds
in each epoch were composed of ts − 20s to ts + 40s, where ts represented the apnea
start time which was obtained from the PSG. Also the 60 second duration epochs
corresponding to time intervals of normal sleep were extracted from both radar and
microphone sensors using information from the scored PSG. All the epochs corre-
sponding to both OA and OH were combined into one class, labeled as Apnea, and
the normal epochs were assigned class label Normal, thus making our task one of
binary classification.
3.1.4 Features Extracted from Radar Epochs
The features were extracted from both the time and frequency domains for each
epoch. A total number of 15 features were extracted from the epochs obtained from
the radar data. We defined fk to be the k-th feature (k = 1,2,...,15). The first eight
features were directly extracted from each epoch. The f9 − f13 were extracted by
first dividing each epoch into small parts of td duration (td = 10sec was chosen as
minimum duration of an apnea event must be 10sec). Let Ei denote a complete
epoch of 60 seconds (i is the epoch number) while em represent a small division of it
(m is the part number, m = 1, 2, ..., 6). Let the variance of time domain respiratory
signal in each em be denoted by σ
2
em . Also let dm be the difference in the upper and
lower envelopes of the small epochs em and σ
2
dm
be its variance. The envelopes were
obtained by cubic interpolation of maximas and minimas. The features f1 to f13 are
explained in Table 1.
In order to extract the features f14 and f15, the average energy of all epochs in the
training set corresponding to normal periods of sleep was calculated and used as a
normalization constant for all the apnea and normal epochs. The apnea epochs were
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Table 1: The first- and second-order features extracted from the IR-UWB epochs
Feature fk Description
f1 Mean Absolute Deviation (MAD) of respiratory signal.
f2 MAD of peaks values of respiratory signal.
f3 Number of times the signal crosses the mean.
f4 Variance of samples between mean crossings.
f5 Variance of maxima-minima intervals.
f6 Variance of maxima-minima amplitude values.
f7 The difference between 75th and 25th percentile of f3.
f8 The sum of power spectral density values between 0− 0.5 Hz.
f9 Variance of [σ
2
e1 , ..., σ
2
e6 ].
f10 Variance of [|σ2e1 − σ
2





f11 Variance of frequency of the highest peak in spectrum of em.
f12 Variance of [σ
2
d1
, ..., σ2d6 ].
f13 Variance of [|σ2d1 − σ
2
d2
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Figure 5: Algorithm for extraction of f15.
not considered in calculation of the normalization constant. The envelope difference
Di was estimated for each epoch Ei and the average envelope difference Bavg was
calculated for the normal epochs. The feature f14 was then calculated as |Di−Bavg|22.
The last feature f15 was extracted to capture the step-like changes in the envelope
at the beginning and ends of the apnea periods. Hence, only apnea epochs in the
training set were used for its extraction. In the processing stage, all the envelope
difference signals corresponding to apnea epochs in the training set were aligned by
apnea start times ts and a 10-second portion (ts−5sec to ts+5sec) was extracted from
each envelope difference signal. Principal component analysis (PCA) was performed
on these 10-second extracted signals. PCA reduces the number of dimensions in the
data set by transforming it into a new set of variables called principal components
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(a) (b)
Figure 6: (a) The principal components extracted from the training data. (b) For-
mation of peak pairs ζu(ηu, τu) (u is the pair number, ηu is the peak value while τu
represents peak position) from the correlation results: for a peak pg in γs, a pair
was formed with peak ph in γe, if pe was the first peak in γe for which τh > τg.
f15 = {ηg + ηh : ηg ∈ ζg, ηh ∈ ζh,max|τg − τh|}.
(PCs), which are statistically orthogonal to each other [48]. Let the principal compo-
nent loading vectors obtained from the 10-second extracted signal, aligned by start
times, be represented by vms , where m is the column or vector number. The envelope
difference signals for apnea epochs were then aligned by apnea end times te and prin-
cipal component analysis was performed on the extracted signals (te−5sec to te+5sec).
Let the loading vectors from PCA on the end signals be represented by vme . The
first PCs from both the start and end sets, i.e., v1s and v
1
e , were selected as these
captured the maximum variation in the data sets. After extracting these loading
vectors, in the feature extraction phase, the Di signal for each epoch was correlated
with both v1s and v
1
e . In general, the correlation of a signal x with y is given as
γ[τ ] =
∑∞
j=−∞ x[j − τ ]y[j], where τ indicates the correlation lag. Let the correlation
of Di with v
1
s be denoted by γs and that with v
1
e by γe for the i-th signal. These
results contained peaks characterized by magnitude and a position or lag value τ as
shown in Fig. 6 (b). In this next step, peak pairs were formed by choosing one peak
from γs and one from γe. In the process of pair formation, for a peak pg chosen from
γs, the peak ph selected from γe was the one that was located immediately after pg as
shown in Fig. 6 (b). Hence, some peaks were not selected in any of the resultant pairs
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evident from Fig. 6 (b). Finally the best peak pair was chosen as the one that had
maximum separation between its constituent peaks as shown in Fig. 6 (b). The sum
of the peak values was chosen as the last feature f15. It is important to mention here
that other features, such as the separation between constituent peaks and product
of peak magnitudes and separation between them in the pair were also considered in
the study. However, none of these were found useful and the best feature was the one
based on sum of the peak values.
3.1.5 Features Extracted from the Microphone
The 7 features extracted from the snores present in each 60-second microphone epoch
included:
3.1.5.1 Features Related to the Pitch of Snores
Each snore was divided into 100ms sliding windows / frames (25% overlap between
consecutive frames). The pitch of the signal in each frame was calculated by the
Autocorrelation Method [34]. First the signal was center-clipped, leaving only the
parts of the signal above the 70% of the maximum amplitude value present in the
signal [34]. The highest peak in the autocorrelation after the main peak was detected
and the position of the peak gave an estimate of the time period. The inverse of this
value was calculated as the pitch ‘P ’. The mean (µP ) of the pitch values across all
frames in a snore was calculated and the mean and standard deviation of µP values
across all snores in an epoch were used features.
3.1.5.2 Features related to Formant Frequencies
Existing research has shown that formant frequencies of snores can be used as a
distinguishing feature between benign and apneic snores. In this context, the first
three formant frequencies were estimated for each of the 100ms frames in the extracted




















Normal Apnea: OA & OH
Figure 7: Division of data during the training and testing phases.
pre-processed by multiplying it with a Hamming window and then using a high-
pass all-pole filter. The linear prediction coefficients were then estimated for the
resulting signal in each frame. The angular frequencies from the roots of the prediction
polynomial were estimated. In this work, the first three formants, f1, f2 and f3, were
selected from each frame and the mean of these values (µf1, µf2, and µf3) were
obtained for each snore. The feature, thus derived from the snores present in each
60-second epoch were the means of the µf1, µf2, and µf3 values estimated from all
the snores present in it.
3.1.5.3 Ratio of Energies in the Power Spectral Density Estimate
The power spectral density (PSD) estimate for each snore was calculated using the
Welch’s periodogram method (100ms frame with 25% overlap) similar to the approach
in [88]. The ratio between the sum of PSD values in the 0 - 300 Hz band and the
sum of PSD values over the entire frequency range was calculated and denoted by rl.
Similarly, rh was calculated as the ratio between the sum of PSD values in the 300
- 800 Hz band and the sum of all PSD values. The mean values of rl and rh for all
snores in an epoch were calculated as a feature.
3.2 IR-UWB based Sleep Apnea Detection
For this section of the study, only the radar signal was processed and used for detection
of apnea events as shown in Fig. 7.
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3.2.1 Training & Testing
The number of apnea epochs na were more than twice the number of epochs ns
corresponding to normal sleep in the data collected for the study. In the training
phase, 10×5 cross-validation (CV) was used in training the classifier. Half the apnea
epochs, i.e., na
2
were randomly selected from the complete set of apnea epochs in
the first step. The randomly selected apnea epochs were divided into 5 folds in the
next step. All the normal epochs ns were also divided into 5 folds. Four folds from
each class were used to train the classifier while the remaining fold from each class
was used for validation. Once 5-fold CV was completed, the classifier was trained on
complete data set which included na
2
and ns normal epochs. The process of feature
subset selection was also embedded in this 5-fold CV step. The wrapper method was
used for feature subset selection [54]. The performance of the trained classifier was
checked on the remaining na
2
apnea epochs from the first step. The whole process
was repeated 10 times as shown in Fig. 7 and the results were averaged through all
iterations.
3.2.2 Results & Discussion
The Linear Discriminant Analysis (LDA) classifier was used for the classification task.
Data was collected from 4 subjects (3 male and 1 female, 48 ± 6.9 years, 210 ± 20.5
lbs and AHI 49 ± 29) who were previously diagnosed with sleep apnea. Full night
recordings (6 - 7 hours) were obtained and after pre-processing, motion detection
and removal, 476 OA, 392 OH and 361 normal epochs (NO) were extracted from the
Table 2: Classification results for apnea (OA & OH) and normal epochs
No. Avg. results cross-validation (validation folds) Test data
of Sensitivity Specificity Accuracy Sensitivity
fk (%) (%) (%) (%)
All 64.6 64 65.6 66
7 71.2 70.8 73.1 67
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recordings. The data was partitioned according to Fig. 7. The results of classification
between Apnea and Normal classes are summarized in Table 2. The classification
results with all features is indicated by “All” in Table 2. The selected feature subsets
have different numbers of features in each iteration. The average number of features
rounded to nearest integer in the selected subsets is shown in Table 2. The values
for sensitivity, specificity and accuracy in the table are for the data in validation
folds of CV phase and averaged through the iterations of 10×5-fold CV. Similarly the
sensitivity for the remaining na
2
apnea epochs in Step 4 of Fig. 7 (listed in the last
column of Table 2) is averaged by the number of iterations in the outer loop.
The results indicate that the classifier when used with complete bag of features
has an overall sensitivity of 64.6% and specificity of 64% during the CV steps and
a sensitivity of 66% for the epochs in the test folds of Step 4 in Fig. 7 . There is
an increase in overall sensitivity, specificity and accuracy when the LDA classifier is
used after feature subset selection. The number of features selected is almost half
the total number of features as the feature subset with lowest number of features is
selected during feature selection.
3.3 Combined IR-UWB radar and Microphone based Sleep
Apnea Detection
The results from the radar based sleep apnea detector did not show good accuracy in
detection of both normal and apnea epochs. One reason for this low accuracy could be
the presence of epochs containing OH events in the collected data set. OH is caused
by partial obstruction of the upper air-way and is accompanied with a less decrease
in respiratory signal amplitude as shown in Fig.8. It is evident from the diagram
that 60-sec epoch containing an OH event is similar to 60-sec epoch corresponding to
normal sleep.
In this part of the study, 7 features from the radar epochs were combined with
the 7 snore-based features from the acoustic data for 3 subjects. One subject did not
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Figure 8: Three 60-sec epochs corresponding to normal sleep, containing a hypopnea
event and an obstructive apnea event.
have audible snores and hence was not included in the study. The 7 features from
the radar data included: f3, f4, f5, f6, f8, f9 and f11 from Table 1.
3.3.1 Training and Testing of the Combined Classifier
In order to check if the classifier worked with the combined feature set from radar
and acoustic data, 5-fold CV was employed and two LDA classifiers were trained as
shown in Fig. 9. In the first step, all the normal (NO), OA and OH epochs were
divided into 5-folds. In 5-fold CV, 4 folds from each class were used to train the
classifier while the remaining fold was used for testing. The process was repeated
until each fold was used as a test fold. In the training phase, two classifiers LDA1 and
LDA2 were trained. LDA1 was trained using radar features only. LDA2 was trained
for those normal and apnea epochs which had a snore present in their corresponding
microphone epochs. As the data were collected from patients with high AHI, the
number of normal epochs were less than the total OA and OH epochs. Hence, before
training, the number of normal epochs presented to LDA1 were upsampled. Let the
difference between the normal and apnea epochs be ∆N . Then ∆N normal epochs









Figure 9: Flowchart for data division in training ans testing phases. The red boxes
indicate that features from snores were also included in classification.
classes. It was observed that snores were absent in more normal epochs as compared
to apnea epochs and hence in order to preserve this difference, the replication was
not done for LDA2 classifier that operated on radar and snore features. All features
were standardized before training with both classifiers. In the testing phase, all the
radar epochs in each test fold were analyzed with LDA1 while only those epochs were
analyzed with LDA2 which included snores in the corresponding microphone epochs.
The sensitivity, specificity and accuracy of both classifiers were calculated for the test
folds and the results were averaged across the 5 iterations of 5-fold CV.
3.3.2 Results & Discussion
A total of 320 NO, 156 OA and 285 OH were extracted from the collected data.
The radar alone classifier, LDA1, showed a sensitivity of 77%, specificity of 64% and
accuracy of 71%. There was an increase in the accuracy from 71% to 76% when the
features from the microphone data were combined with the radar features in LDA2.
Similarly, the sensitivity of LDA2 was found to be 80% for the radar epochs which had
snores present in the corresponding microphone epochs. The specificity for combined
classification was 70%.
It was observed that adding the snore features from the microphone epochs im-
proved the classification performance. The gain in accuracy was on average 5% and
might not indicate a significant increase. However, one contributing factor to it is the
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sub-optimal location of the microphone sensors in this work. Usually, the microphone
is placed on the neck or hung from a fixed support (such as ceiling) so that it stays
few inches away from subject’s face. The aim of this initial work was to come up with
a overall system that does not put stringent constraints on subjects with regards to
operation. Hence, future work should focus on adding multiple microphones placed
or attached at different locations near the bed. The signal from multiple microphones
can be combined, using beamforming techniques, to give better performance.
3.4 Limitations of the Work
One limitation of this preliminary work, was the small sample size involving only 3
subjects. Since it was a feasibility study, data should be collected more subjects which
will lead to improvement in the classification results. Future work should also focus






An important limitation in the field of BCG research is that while the BCG signal
measures forces of the body, the information desired by clinicians and caregivers
regarding mechanical health of the heart is typically expressed as blood pressure or
in terms of parameters related to the flow of the blood. The understanding of the
precise origin of the BCG signal and how the signal mathematically relates to blood
pressure and aortic blood flow is limited and represents a fundamental scientific gap
that must be addressed for the BCG to be adopted in clinical use.
The aim of this work was to explore the mathematical relationship between the
BCG signal and the better-understood ICG and ABP waveforms, with a series of hu-
man subjects studies designed to modulate cardiac output (CO) and blood pressure
asynchronously and with different magnitudes. One might consider directly mea-
suring the ABP or blood flow parameters such as CO in the home rather than to
measure the BCG in the first place and then attempt to relate it to these modalities.
However, the current tools and devices for measuring the ABP and CO continuously
are obtrusive, expensive and require a trained medical personnel to administer the
measurement. The ABP is measured using volume-clamping finger-cuffs [10], while
the CO (CO = stroke volume × heartrate), can be estimated from the ICG signals
[3, 33], using eight electrodes placed precisely on the neck and thorax by a medical
professional. Significant research efforts over the past several decades have led to















Figure 10: Physiological phenomena associated with the action of heart. The forced
ejection of blood into the aorta (represented by the force vector ~FH) is characterized
by blood pressure (derived from ABP, waveforms), blood flow (derived from ICG
waveforms) and whole body movement (derived from BCG waveforms). Analyzing
the relationship between BCG and ABP or ICG waveforms can provide insight into
the hemodynamic origin of the BCG and thereby improve the ability to derive car-
diovascular health parameters from this signal.
ABP and thoracic ICG waveforms. If the BCG waveform, which can be measured by
unobtrusive, inexpensive, and simple hardware readily deployable in home settings,
could be anchored to either of these well-understood measurement modalities, then
ABP and CO can be readily measured at home.
The objective of this study was to analyze if the BCG signal was more in accord
with the pressure of the blood or its flow, as shown in Fig. 10. It is important to
mention here that while pulse pressure (PP)—which is the difference between sys-
tolic (SP) and diastolic (DP) blood pressure values—is closely related to CO, the
relationship changes significantly throughout the day. For example, exercise, stress,
or even simply fluctuations in ambient temperature can cause total peripheral resis-
tance (TPR), the parameter that links PP to CO (specifically, PP = CO x PP), to
change dramatically. In order to better understand the origin of the BCG, we first
extracted features from the weighing scale BCG heartbeats and assessed correlations
of these features with the corresponding features from the ABP and ICG heartbeats.
Next, a method was designed to map the BCG heartbeats into corresponding ICG
and ABP waveforms. The performance of the method was analyzed by using the


















Rest Valsalva Recovery Handgrip Recovery 
4.8 ± 5.1ΔSV (ml):
ΔSystolic (mmHg):
(60s) (15s) (60s) (30s) (30s) 
−1.1 ± 8 −1.9 ± 4.3
−3.2 ± 6.8 12 ± 11 −0.8 ± 13
𝑤𝑖𝑛pre-R
R-peak
Figure 11: (a) Experimental setup and processing steps for the measured signals. (b)
Different phases of the data protocol used for collection of data from each subject.
The mean and standard deviation for change in PP and SV are shown for different
phases in the protocol. The values shown are for post-Valsalva recovery, handgrip
and post-handgrip recovery phases.
(SV). Finally, the performance of the proposed BCG-to-ICG mapping method was
assessed in a single-subject multi-day trial that involved estiamtion of cardiac out-
put using the modified-weighing scale sensor. This work could provide a tool, for
example, for monitoring HF patients at home following discharge from the hospital,
with the goal of potentially predicting exacerbations and thus reducing unnecessary
re-hospitalizations.
4.2 Protocol
The data for the study were collected from nineteen healthy subjects under an IRB
protocol approved by Georgia Institute of Technology (subject demographics: 5 fe-
males and 14 males, 24.4 ± 4.8 years old, 175 ± 8.8 cm tall and weighing 71 ± 12.5
kg). The aim of the protocol was to create changes in SV and blood pressure through
perturbations as shown in Fig. 11. It consisted of five phases with two perturbations
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separated by recovery time. Each subject stood on the BCG weighing scale in a rest-
ing state for 60 seconds. Then a Valsalva maneuver was performed for 15 seconds.
During a Valsalva maneuver, a person forcefully expires against a closed airway, usu-
ally done by closing one’s mouth and nose while ‘bearing down’ as blowing a balloon.
This causes changes in intrathoracic pressure and dramatically affects venous return,
arterial pressure, cardiac output and heart rate [76]. The Valsalva maneuver was
followed by a recovery period of 60 seconds. Finally, each subject performed a hand-
grip exercise for 30 seconds that was also followed by 30 seconds of recovery. The
handgrip exercise is an isometric (static) exercise that involves application of force
without a change in muscle length. During an isometric exercise, the blood pressure
rises due to increase in intramuscular pressure caused by stiffening of active muscle
fibres [84]. The data in these phases was then used to analyze if the BCG captured
more of the variability in SV or PP. The subjects stood in an upright posture on
the weighing scale during the whole protocol. The ECG, ICG and ABP were all col-
lected simultaneously with the BCG. A volume-clamping finger-cuff device was used
to continuously measure the ABP.
4.3 Hardware & Data Processing
The ECG and ICG signals were measured using the BN-EL50 and BN-NICO wireless
measurement modules (BIOPAC Systems, Inc., Goleta, CA) and then transmitted
wirelessly to the data acquisition systems (MP150WSW, BIOPAC Systems, Inc.,
Goleta, CA). The ABP was measured non-invasively and on a continuous beat-by-
beat basis with the A2SYS Nexfin Monitor (Edwards Lifesciences, Irvine, CA) that
uses the volume-clamping technique on one finger [10]. The BCG signal was measured
with a modified weighing scale using the strain gauge bridge and an analog amplifier
[42]. All the signals were sampled at 1 kHz.
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The signals from three measurement modalities, ICG, BCG and ECG, were fil-
tered with finite impulse response (FIR) Kaiser window band-pass filters (cut-off
frequencies: 0.8-35 Hz for the ICG, 0.8-15 Hz for the BCG and 2.5-40 Hz for the
ECG). The ABP signals were only low-pass filtered (FIR, Kaiser window, cut-off:
20Hz) to preserve the DC value and to estimate the accurate values of systolic and
diastolic blood pressure values. The R-peaks in the ECG signal, denoted by Ri (i
represented the peak index), were detected using a simple peak detection algorithm
and results were manually verified to make sure all peaks were detected correctly.
Specifically, local maximas in the ECG signal above a pre-defined threshold (50% of
the maximum signal amplitude) were detected as R-peaks. The R-peaks which were
closer than 300ms were later discarded as false positives. The minimum R-R interval
was calculated in each phase of the data collection protocol for each subject. Let the
minimum R-R interval in each phase be denoted by winα (α represents the phase,
i.e., α ∈ [rest, V alsalva, recovery, handgrip, recovery]). With the ECG R-peaks as
reference, the BCG, ICG and ABP signals were segmented into individual heart-
beats or frames [47]. Each frame contained samples from 300ms before the R-peak
and winα samples after the R-peak, i.e., one heartbeat = Ri − 300ms to Ri + winα,
as shown in Fig. 11 (a). The first 300ms portion in the extracted heartbeats are
refered to as pre-R samples in Fig. 11 (a). All the beats extracted in each of the
phases were ensemble averaged [93] to reduce noise and features were extracted from
the ensemble-averaged traces. The data from the 15-second Valsalva period were not
analyzed as these included noise caused by subject-induced movement during the Val-
salva maneuver. Hence for each subject, four ensemble-averaged traces corresponding
to rest, post-Valsalva recovery period, handgrip and post-handgrip recovery period












































Figure 12: (a) Extraction of features from the heartbeats of three measurement
modalities. (b) Block diagram from system identification based mapping of the BCG
heartbeats to the ICG and ABP heartbeats. The system was trained for data in
the resting phase of each subject and then tested on the data from the perturbation
phases.
4.4 Extraction of Features from the BCG, ICG & ABP
In order to better understand the BCG-to-ICG and BCG-to-ABP relationships, we
extracted a number of features from the BCG heartbeats and correlated (Pearsons
correlation) these with the features obtained from the ICG and ABP. The annotated
BCG, ICG and ABP heartbeats are shown in Fig. 12 (a). The features extracted
from these three modalities are explained in the following sections:
4.4.1 Features derived from the BCG
The three features extracted from the BCG heartbeats included: (1) the I-J amplitude
normalized by root mean square (RMS) energy in the heartbeat, i.e., I-J/ERMS, where
ERMS represented the root mean square energy in the BCG heartbeat / frame and is






b2i (n is the total number of samples in a BCG heartbeat b),
(2) the R-J interval, i.e., the time interval between the ECG R-peak and the J-peak
on the BCG heartbeat, and (3) the (M-K interval × I-J amplitude)/ ERMS, where M
corresponded to the point of maximum slope. The hypothesis behind multiplying the
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BCG amplitude value and time interval feature was to design a feature that could
capture the energy of the main BCG complex and to quantify the mechanical energy
in each heartbeat, which could potentially increase with increased SV.
4.4.2 Features derived from the ICG
The three features extracted from the ICG heartbeats included: (1) the maximum
peak value in the heartbeat, i.e., the dz
dtmax
value corresponding to the maximal speed
of blood ejection, (2) the PEP, i.e., the time difference between the ECG R-peak and
the B-point on the ICG called the R-B interval, and (3) the time difference between
the X- and the B-point representing the LVET. These features characterized the blood
flow in the vessels and were required for estimation of SV from the ICG [3].
4.4.3 Features derived from the ABP
The three features from the ABP heartbeats included: (1) the systolic blood pressure
value obtained by detecting the maximum peak Sp in the heartbeat, (2) the foot
value Dp before the maximum peak, denoting the diastolic blood pressure, and (3)
the difference between Sp and Dp values called the PP [81].
4.5 Mapping the BCG to Other Modalities
In order to further analyze the relationship between the BCG and ICG / ABP, the
BCG heartbeats were separately mapped to the corresponding ICG and ABP heart-
beats using subject-specific FIR system identification methods. An impulse response
was estimated for a subject-specific linear FIR filter that converted the BCG heart-
beats to the ICG heartbeats and another impulse response for the BCG to ABP
conversion.
In general, the output vector y of a linear filter of order Q operating on an input
vector x is obtained by convolving the impulse response w of the filter with the input
(x,y ∈ RN and w ∈ RQ). In the least squares terminology, the output is given by
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the equation
y = Xw, (1)
where X is the convolution matrix whose entries are made up of elements of x. If
the input vector is zero-padded to account for unavailable data during the convolution
operation, then this method is called the Auto-correlation method [40]. If the elements
of output y, input x and impulse response w are represented by corresponding italic
letters, then the matrices involved in equation (1) will be given by
y =
[
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
. (4)
Let the desired output signal be ŷ, then the optimum solution (impulse response)
ŵ can be obtained by minimizing the expression
min
w
‖Xŵ − ŷ‖2. (5)
The impulse response ŵ of the filter is then obtained as
ŵ = (XTX)−1XT ŷ. (6)
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Since ordinary least squares is highly sensitive to noise, ŵ can be regularized by
adding a term λ to the minimization expression in equation (5). This process is
called Tikhonov regularization [35]. In other words, the solution approaches ordinary
least squares solution as λ → 0 and to 0 as λ → ∞. The objective of λ, called
regularization constant, is to avoid over-fitting. The modified minimization expression
and the Tikhonov regularized solution are now given as
min
w
‖Xŵ − ŷ‖2 + λ‖ŵ‖2, (7)
ŵ = (XTX + λI)−1XT ŷ. (8)
In this study, the heartbeats from the 60-second resting portion of the BCG, ICG
and ABP data for each subject were used to train the systems. We employed 5×2-
fold CV [4] in the training phase and the performance of the trained systems was
checked on the perturbation phases of the data protocol as shown in Fig. 12 (b). The
objective was to find the optimum filter length (Q), number of samples before the
Ri peak in each frame (pre-R samples) and the value of the regularization constant
λ that provided the least error in mapping the BCG heartbeat (one frame) either
to the ICG heartbeat or to the ABP heartbeat. This was accomplished by sweeping
through filter lengths from 1 to 500 samples, 0 to 300 pre-R samples and values of
λ(10−6 to 10−1) in the training phase using 5×2 CV.
In subject-specific BCG to ICG mapping, for each combination of the above men-
tioned three parameters (Q, pre-R samples and λ), the BCG and ICG heartbeats
in the resting phase data of each subject were randomly partitioned into 2-folds re-
spectively. One fold from each modality was used in training while the other fold
was used in validation phase. In the training phase, ensemble-averaged traces from
one of the BCG and ICG folds were used as the input x and output y. The filter
impulse response ŵ was then estimated according to equation (8). Once the ŵ was
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obtained, the ensemble-averaged trace from the other BCG fold was converted to
an ICG trace (say ŷ) and the error (Euclidean distance) was calculated between ŷ
and the ensemble-averaged trace from the remaining ICG fold. The above process
was repeated for the different combinations of Q, pre-R and λ values using 5×2-fold
CV. The combination of the three parameters that gave the minimum error was then
chosen to design a BCG-to-ICG filter (FIR) for that subject. A similar process was
adopted to obtain subject-specific FIR filters to convert the BCG heartbeats to the
corresponding ABP heartbeats.
Once subject-specific FIR filters were generated, they were used to convert the
ensemble-averaged traces in the post-Valsalva recovery, handgrip and post-handgrip
recovery phases into the corresponding ICG and ABP waveforms. For the ICG, the
points of interest that include the B-, dz
dtmax
and the X-point as shown in Fig. 12 (a),
were detected on the true ICG traces and also on the waveforms obtained from the








where H denotes the subjects height and Zo represents the base impedance. The
Zo value was estimated as the foot of the ensemble averaged heartbeats of the raw
impedance signal obtained from the ICG [3]. The value of Zo, which could be con-
sidered as a constant, was estimated only in the resting phase for each subject and
the same value was used during the perturbation phases. Let SV during the first
60-seconds of rest be represented by SVrest and during the other phases be denoted
by SVα. The percentage change in SV during phase α was then calculated using the
equation ∆SV = (SVα − SVrest)/SVrest. A linear regression / correlation analysis
(Pearsons) was done between the values ∆SVICG obtained from the ICG waveforms
and ∆SVSys values obtained from the trained filters from all subjects. The outliers
in ∆SV estimates from both the ICG and the trained systems were detected using
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the minimum-covariance distance (MCD) estimator [79] and were removed before
correlation analysis.
Similarly, the points corresponding to Sp and Dp were detected in the true ABP
waveforms and the ABP waveforms obtained from the FIR filters trained for mapping
the BCG to ABP. The percentage change in PP for phases other than resting state
was calculated as ∆PP = (PPα − PPrest)/PPrest and correlation analysis was done
for ∆PP data points obtained from the true and converted ABP waveforms for all
subjects. The MCD method was again used to detect and remove outliers from the
analysis.
4.6 Single-Subject Multi-Day Hemodynamic Assessment
In order to analyze the long-term performance of the above system identification
based mapping method, we also collected data from one subject (24 years, 58kg,
162cm height) for five consecutive days. The objective was to assess the feasibility
of training an FIR filter on the first day to convert BCG heartbeats to the ICG
heartbeats and then assessing its performance on the remaining days for estimation
of SV from the BCG. On all 5 days, the subject was asked to stand still for 2 minutes
on the BCG weighing scale while BCG, ECG and ICG data was collected from him.
An impulse response to map the BCG heartbeat to the ICG heartbeat was obtained
from the first day using the method described earlier. The data on each of the
remaining 4 days was ensemble averaged and used as input for the trained filter from
the first day.
4.7 Results
4.7.1 Correlation Results from Waveform Features
The features extracted from the BCG heartbeats of 19 subjects in the post-Valsalva,
handgrip and recovery phases showed good statistically significant correlation with the










Figure 13: (a) Correlation results for SV values obtained from the BCG mapped
waveforms and the ICG waveforms. The relationship is statistically significant (p <
0.05) (b) Correlation results for change in PP from the BCG mapped and original
ABP waveforms. N represents the total number of data points while n denotes the
number of data points considered in the analysis after outlier rejection.
features from the ABP heartbeats. The I-J amplitude normalized by the root mean
square energy of the BCG heartbeat showed a correlation value of r = 0.61 (p < 0.05)
with dz
dtmax
and also a value of r = 0.58 (p < 0.05) with the LVET from the ICG. The
ICG maximum peak dz
dtmax
also showed a good correlation (r = 0.71, p < 0.05) with
(M-K interval × I-J amplitude)/ERMS. The R-J intervals obtained from the BCG
heartbeats displayed a correlation of 0.75 (p < 0.01) with PEP (R-B interval) from
the ICG, which is in agreement with a previous study [28].
All the amplitude and time based features from the BCG showed poor correlation
with Sp, Dp and PP and hence are not explicitly reported here. The correlation values
for all such comparisons were less than 0.05 and were also not statistically significant,







Day 1 Day 2 - 5
Test Days 2nd 3rd 4th 5th
Error in SV (ml) 0.45 7 -1.6 1.7
Error Results for Single Subject Stroke Volume Estimates from the BCG
Figure 14: Single subject multi-day trial results. The system was trained on the 1st
day and tested on the remaining 4 days for estimation of SV from the BCG signals.
4.7.2 BCG Mapping Results
The subject-specific BCG-to-ICG mapping FIR filters, obtained from the resting
phase heartbeats, were tested on the ensemble-averaged BCG traces from the post-
Valsalva recovery period, handgrip and post-handgrip recovery phases for each sub-
ject. The ∆SV values were estimated from the filter generated and the true ensemble-
averaged ICG traces in the three phases. Hence, three data points were obtained for
each subject. The correlation results for percentage change in SV are summarized
in Fig. 13 (a), which shows a correlation value of 0.73 (p < 0.05) for all subjects.
Similarly, the BCG ensemble-averaged waveforms in the post-Valsalva, handgrip and
recovery phases were also converted to the corresponding ABP waveforms using the
subject specific BCG-to-ABP FIR filters. The percentage change in the PP estimated
from the converted waveforms shows a correlation value of 0.25 with the corresponding
values from true ABP waveforms in these phases.
4.7.3 Single-Subject Results
The results for single subject multi-day trial using the proposed system identification
method are shown in Fig. 14. The ICG waveforms obtained from the BCG-to-ICG
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FIR system were used to calculate SV on the test days. The results were compared
with the corresponding SV values from the measured ICG. The trained system per-
formed well on the testing days as the errors in SV from the ICG measurements and
SV from the system estimated waveforms are very small on 3 of the 4 test days. There
is a difference of 7 ml in the FIR based estimated and ICG based SV on the third day.
The reason for this huge error on the third was found to be the low signal-to-noise
ratio of the BCG signals due to the presence of motion artifacts.
4.8 Discussion
From the results derived in the previous sections, we conclude that leveraging the
common features of BCG and ICG waveforms may provide a methodology by which
hemodynamic parameters such as SV, pre-ejection period and left-ventricle ejection
time can be extracted from BCG waveforms. The mapping technique presented in
this study also shows that the BCG waveforms can accurately capture corresponding
changes in ICG waveforms and, thus, changes in hemodynamic parameters. On the
contrary, the features derived from the arterial blood pressure waveforms which in-
clude systolic blood pressure, diastolic blood pressure and PP associated with them
do not show any significant relationship with the BCG-derived features and the BCG
waveforms do not capture the change in blood pressure parameters. It has been
shown in recent research that the BCG waveforms be used to provide a proximal
timing reference for measurement of pulse transit time (PTT) to assist in ubiquitous
monitoring for blood pressure [51, 65]. The pulse transit time, defined as the time
interval required for a pressure wave to travel between two points on the arterial tree,
has been shown to have a strong inverse relationship with blood pressure. To the
best of our knowledge, this is the first time the BCG-to-ABP relationship has been
explored on the basis of features derived from the two measurement modalities.
The results also suggest that the BCG phenomenon is more related with blood flow
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curve as compared to the arterial pressure curve. The methods used for extraction
of features from the ICG and ABP waveforms in this study are based on the existing
literature regarding these two measurement modalities [3, 51]. On the other hand, the
BCG based features, which are composed of different time intervals and amplitudes
of different points on the BCG wave, are extracted to capture changes in the flow of
blood.
The data for this study were collected from 19 healthy subjects which included 5
females and 14 males. However, no gender related differences were observed in the
results. Another highlight of the work presented is that the proposed methods can be
used with other BCG measuring sensors, such as wearable accelerometers, and also in
settings other than the home for continuous assessment of hemodynamic parameters.
However, correct estimation of these hemodynamic parameters require that the signal
is free from all motion artifacts. The results from the single subject multi-day trial
also corroborate this notion as an error of 7ml in the BCG- and ICG-estimated SV was
observed on one of the test days. After further investigation into that days results, it
was found that presence of motion artifacts in the measured signals, caused by even
the slightest inadvertent subject motion, introduced errors in the mapping technique
and thus rendered incorrect results. Hence, either the data should be free from all
types of motion artifacts or algorithms should be designed to adaptively mitigate the
effect of these artifacts and also improve the estimation accuracy.
4.9 Conclusion
In this study, we have systematically compared the BCG measurements obtained
from a modified electronic weighing scale with the hemodynamic measurements from
the ICG and ABP sensors. The results derived in this study not only provide insight
into the physiological origin of the BCG but can also lead to design and implementa-
tion of algorithms and methods for using the BCG measurements for cardiac output
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evaluation as well as cardiac contractility in unsupervised environments outside of
the clinic.
An important limitation of this study was that data was collected from relatively
young and healthy subjects. Hence, future work should include a more diverse group
of participants and also subjects with cardiovascular disease. Moreover, work with
additional subjects is also needed to validate the findings of the multi-day trial fea-
sibility study presented in this work. The methods presented in this manuscript
represent early translational work with the aim of providing a solution to monitoring
HF patients at home and potentially predicting exacerbation using the BCG-derived
cardiac output estimates. Predicting an HF exacerbation fundamentally requires the
accurate measurement of cardiac output, and / or the components that it is derived
from. Accordingly, the ability to accurately derive cardiac output changes from BCG
recordings is a central element towards BCG-based scales being translated into use
for monitoring HF patients at home.
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CHAPTER V
POSTURE INDUCED DISTORTION IN
BALLISTOCARDIOGRAM SIGNALS
5.1 Introduction
As the BCG is a measurement of the mechanical vibrations of the body in response
to the heartbeat, the posture of the subject during the measurement can impact the
quality of the signals. While intuitively this concept is sound, an in-depth, quan-
titative study of posture-induced distortion in BCG measurements has never been
conducted. Understanding the nature of these distortions can greatly improve the
ability to interpret BCG recordings in unsupervised settings—such as the home—by
allowing the automatic identification of measurements taken from subjects with in-
correct posture. These measurements can then be flagged and treated differently such
that the distortion due to posture is not confused with changes in the BCG signal
associated with changing cardiovascular health.
The requirement to stand in an upright posture poses limitations on the use of
BCG in non-clinical environmens. In addition to a subject accidentally slouching
forward for a measurement, it is possible that some subjects will have reduced physical
strength, and thus the measurements must be taken in a seated position instead. It
has been shown in different studies that the BCG signal can be affected by posture,
using various measurement hardware such as fiber optic sensors [24, 55]. However,
these postural effects have not been studied in depth.
In this study, we focused on the posture induced changes in the BCG signals from
two sensors: (1) weighing scale, and (2) wearable accelerometer. The weighing scale
form factor offers many benefits which include: (1) weighing scales are common in
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almost every household in the US, (2) the sensors present in the weighing scale are
already very sensitive and require slight addition and modifications for measuring the
BCG, and (3) other sensors can be integrated into the weighing scale assembly for
multi-modal patient monitoring at homes. The accelerometers, on the other hand,
have emerged as a front-runner among sensors for wearable health monitoring. Their
low-cost, miniature size and extreme sensitivity to vibrations make them ideal for
wearable BCG measurements.
In the next section, we shall discuss the effect of different postures, standing and
seated, on the weighing scale BCG. This will be followed by analysis of posture on
wearable BCG from accelerometer signals in three different standing postures.
5.2 Effect of Posture on Weighing Scale BCG
The weighing scale BCG, as discussed earlier, provides many benefits which not only
include benefits related to form factor and cost, but also that weighing scales are
popular in millions of homes in the world. The objective of this work was to (1)
investigate the changes in the BCG signal and derived parameters under different
postures and positions, and (2) demonstrate novel methods based on our recent work
[104, 103] to improve the system performance for seated postures. Specifically, we
focus on improving the estimation of R-J intervals from the ECG and BCG, as a
surrogate measure of contractility [44, 60], and evaluate our results based on standard
measurements of the PEP from the ICG signals [3, 18]. The novel methods described
in this work can improve the usability of the BCG scale in unsupervised settings (i.e.
the home), by improving robustness to seated posture, as well as enabling high quality
seated BCG measurements which would expand the available patient population.
5.2.1 Protocol for Data Collection
The data for the work were collected from 13 healthy subjects (12 male and one female,















































Figure 15: (a) Experimental setup. Three standing postures: upright (θS ≈ 0◦),
slightly slouched (θS = 20 − 40◦) and heavily slouched (θS = 40 − 60◦). Two seated
postures: upright(θk = 90
◦) and bent knee upright(θK = 60 − 80◦). (b) The BCG
heartbeats in standing postures.
approved by Georgia Institute of Technology IRB and written consent was obtained
from each subject before data collection. Each subject was asked to stand on the
weighing scale in three different postures characterized by the angle θS made by
upper back (more specifically the angle formed between the line joining the T2-T4
vertebrae) and sit on the weighing scale in two different postures defined by the knee
angle θK as shown in Fig. 15. Each subject was asked to keep his or her back in an
upright position for the two seated postures. Thus the five postures considered in the
study are described below:
• Posture 1 (P1): Upright standing position where θS ≈ 0◦.
• Posture 2 (P2): Slightly slouched standing position where θS = 20 ∼ 40◦.
• Posture 3 (P3): Heavily slouched standing position where θS = 40◦ ∼ 60◦.
• Posture 4 (P4): Seated position where knee angle θK ≈ 90◦.
• Posture 5 (P5): Seated position where knee angle is θK = 60◦ ∼ 80◦.
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The standing upright posture can be considered as a “gold-standard” posture
and provides the best coupling of vertical (head-to-foot) cardiac forces to the scale
as shown in previous studies [43, 44, 45, 36]. The two other standing postures, P2
and P3, were considered as these would simply represent the user accidentally taking
measurements without standing completely upright or due to back problems. The
upright sitting posture (P4) was considered since some patients are not able to stand
still on the scale. Such seated BCG measurements have also been considered in
the literature [45, 75], but these do not consider the important comparison of signal
quality and feature accuracy from the measured BCG signal. Finally, the last posture
P5 in this study was used to explore the increase in pressure wave reflections at the
femoral bifurcation and how these reflections affect the BCG.
In the standing upright posture (P1) and the upright sitting posture (P4), each
subject was asked to stand still for 30 seconds and then perform a Valsalva maneuver
for 15 seconds. This was followed by a recovery period of 30-40 seconds in stationary
state. In the remaining standing and sitting postures, each subject was asked to stand
or sit in a stationary state for 30-40 seconds. The data from the 15s Valsalva period
was not analyzed due to motion artifacts. The purpose of Valsalva was to modulate
the hemodynamic parameters.
5.2.2 Hardware Design & Data Processing
The BCG was measured using a custom analog amplifier as described in the previous
chapter. The ECG and ICG signals were measured using the BN-EL50 and BN-
NICO wireless measurement modules (BIOPAC Systems, Inc., Goleta, CA) as in the
study of Chapter IV and then transmitted wirelessly to the data acquisition system
(MP150WSW, BIOPAC Systems, Inc., Goleta, CA). All the signals were sampled at
a frequency of 1 kHz.
Once the data was recorded, the processing steps for the measured signals were
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the same as in previous chapter. The ECG, ICG and BCG signal were band-pass
filtered with FIR filters (Kaiser window with cut-off frequencies: 2.5 - 40 Hz for the
ECG, 0.8 - 35 Hz for the ICG and 0.8 - 15 Hz for the weighing scale BCG. After
the signals were filtered, the R-peaks, Rr (r was the peak index), in the ECG signal
were automatically detected with a QRS complex detection algorithm and used as
fiduciary points for segmenting the BCG data. Specifically, the signals in Rr + 600ms
frames or “heartbeats” following each R-peak were extracted over the entire data
period and aligned to form a collection or an ensemble. Let the individual frames or
heartbeats from the BCG, ICG signals be represented by small letters bk,m and ik,m,
respectively (bk,m ∈ RM×d, where k denotes posture, k ∈ [1, 2, ..., 5], m represents the
number of heartbeats in one posture for a subject, m ∈ R and maximum number of
heartbeats is M). Each sample in a BCG or ICG heartbeat be denoted by bk,m[l],
where l is the sample number, l ∈ Rd and d = 600 due to frame size. Let the BCG
trace obtained by averaging all the heartbeats bk,m in one posture be denoted by the
bold letter Bk. Similarly, Ik be the averaged ICG trace.
5.2.3 Time Domain Posture-Induced Differences
In order to analyze posture-induced differences in the time domain, we calculated for
each subject and posture the RMS difference between each normalized BCG frame
bk,m and its corresponding average Bk. We termed this difference as an “error” in
shape of individual BCG frames and the corresponding average trace. The normal-
ization constant was calculated in the form of a scaling factor for each frame that
minimized this RMS error. Because of this normalization, the RMS error quantified
shape distortion that could not be corrected by a scaling factor. For the m-th unnor-
malized BCG frame bjk,m for subject j in posture k and average B
j
k, the amplitude
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The RMS errors thus calculated by (11) for postures P2, P3, P4 and P5 for each
subject. These values were then normalized by division from the corresponding error
in posture P1 for that subject. Let ẽk represented this normalized error for a subject
in posture k-th posture. The mean and standard deviation of ẽk was then calculated
for all subjects in the k-th posture.
5.2.4 Frequency Domain Posture-Induced Differences
The PSD was estimated using the Discrete Fourier Transform (DFT) of BCG average
Bk of each subject only in the three standing postures. The PSD estimates were
interpolated to increase the resolution by a factor of four. Let Xk[f ] denoted the
PSD estimate, where k again denoted the posture (k ∈ [1, 2, 3]) and f represented
the frequency index. The mean and the standard deviation of PSD for f = 0 → 14
Hz were calculated for each of the standing posture for all the subjects.
5.2.5 Parameter Extraction
The R-J intervals and PEP were calculated from the extracted heartbeats for each
subject in all postures. However, instead of using the average trace for all the heart-
beats for a subject, the heartbeats in 5-second periods were averaged to increase the
number of data points. Since the 15 second post-Valsalva period was also included
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in the data for P1 and P4 for all subjects, the heartbeats from the post-Valsalva 15
second period were also divided into sub-ensembles.
The J-peak in the BCG ensemble-averaged waveform was detected as the global
peak in the first 400ms portion of the signal. Apart from the R-J interval, the R-K and
the R-I intervals were also calculated. However, the R-J interval measurement was
a more consistent feature in the BCG signal and the J-wave was larger in amplitude
than either the I- or the K-wave. Thus the J-peak was more easily identifiable as
it was less corrupted by noise and motion artifacts. Additionally, the R-J interval
had been shown in previous papers [28, 36, 44] to be correlated to the PEP both for
subjects at rest and with the use of physiological perturbations.
The PEP was extracted from an ICG waveform using the same method as in
Chapter IV. The PEP was defined as the time elapsed from the R-point in the ECG
to the B-point on the ICG signal.
5.2.6 Improved Feature Estimation from Seated BCG
It was observed from the data collected in the study that the J-wave amplitude and
morphology for the seated BCG signals was significantly different from the standing
measurements from the same subjects. In order to improve the noise reduction per-
formance of the ensemble averaging, we employed weighted averaging techniques as
described in [93]. It was also observed that the J-wave could split into two smaller
peaks in some heartbeats leading to peak detection errors. In order to mitigate this
problem, we devised a simple algorithm for consistently detecting J-wave peak based
on low order polynomial fitting. First, the highest peak (p′) was detected between
150 and 400ms portion of the weighted ensemble averaged BCG waveform. The zero-
crossings before and after p′ were then determined and a polynomial of order 2 was
fitted across the waveform between these zero-crossings containing p′ as shown in








Figure 16: Modified R-J interval estimation method from the weighing scale BCG in
sitting postures.
J-peak (say J′-peak) and the R-J interval was estimated as the time period between
the newly detected J′-peak and the ECG R-peak.
Along with the improvement of R-J interval from seated postures, a system iden-
tification based method was designed for improved estimation of R-J intervals from
the two slouched postures [47]. However, since it was collaboration work, the method
along with the results will not be discussed here. The interested readers are referred
to [47] for more details.
5.2.7 Statistical Analysis of Estimated Parameters
In order to analyze the improvement with the above modified method of J-peak
detection in the seated postures, a paired t-test was conducted on absolute values
of residuals of PEP from the regression line before and after the application of the
polynomial fitting method. To remove the outliers in the linear regression model
fitting the R-J interval to PEP, the mean (µ) and standard deviation (σ) of both
PEP and R-J intervals was calculated for all subjects in each of the two sitting
postures. The data points for which either PEP values or the R-J intervals were
beyond their respective µ ± 2σ values were then removed from the analysis for that
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(a) (c) (b) 
Figure 17: Average power spectra with standard deviations for all subjects. (a)
Upright standing. (b) Slightly slouched standing. (c) Heavily slouched standing.
sitting posture. In order to remove additional outliers, the data points for which the
squared Mahalanobis distance [22] was greater than χ20.95 were also removed from the
analysis.
The objective for implementing this 2-tier outlier detection was that Mahalanobis
distance, which finds outliers in multivariate regression, depended on the joint mean
of the multivariate data and was affected by one or two erroneous points occurring at
the extremes. Since the paired t-test required equal number of data points, the union
set of outliers were removed from the R-J intervals and PEP data points before and
after the application of improvement methods.
5.2.8 Results
It was observed that the mean and standard deviation of the normalized error ẽk
exhibited an increasing trend across postures indicating more shape distortion in
the measured BCG for bad postures. The values of normalized error calculated for
slouched and seated postures were : 0.85 ± 0.25 (slightly slouched), 1.1 ± 0.5 (heavily
slouched), 1.7± 1.1 (upright sitting) and 2.5± 1.8 (knees raised). The PSD results for
the three standing postures are summarized in Fig. 17 which show the appearance of






















Figure 18: Correlation results. (a) Upright standing. (b) Slightly slouched standing.
(c) Heavily slouched standing. (d) Upright sitting (e) Bent knees sitting. N is the
total number of data points while n is the number of data points used in linear
regression after removing the outliers.
The correlation between R-J interval and PEP for upright standing posture was
r = 0.85, while the system identification based methods discussed in [47] resulted
in correlation values of 0.65 and 0.54 for posture P2 and P3 respectively. The avid
reader is referred to [47] for more details. The correlation results between the R-J
interval from the BCG heartbeats and the PEP from the ICG in the seated postures
are shown in Fig. 18. There was a statistically significant increase in correlation
between the R-J interval and PEP for upright sitting posture when the modified R-J
interval estimation is employed. The correlation increased from 0.7 to 0.84 for the
upright sitting. There was a small increase from 0.65 to 0.7 in correlation between
the R-J intervals and PEP for the knees raised sitting posture. However, this increase
was not statistically significant.
5.3 Discussion & Limitations
The results derived in this work with weighing scale BCG indicated the presence
of features in the measured signals that can be used to detect change in posture
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as compared to a change in cardiovascular physiology. Specifically, the frequency
domain analysis showed the appearance of second peak beyond 6Hz, in addition to
the global spectral peak in the 0-6 Hz band, for the slouched standing postures. The
peak became more prominent as the posture became more slouched indicating that
more distortion was present in the weighing scale BCG signal. These additional peaks
could also be contributed to other modes of vibration present in the slouched standing
postures. A similar effect has been observed in the seated postures in previous studies
[52, 61].
It can also be concluded from the results that with the help of suitable methods
such as the polynomial fitting based R-J estimation method presented in this work,
the J-peak can be detected more accurately for the sitting postures. This is evident
from the increase in the correlation for the upright sitting posture. The improved
correlation for the upright sitting posture approached the value of correlation between
the R-J intervals and PEP for the “gold-standard” upright standing posture. Hence,
similar methods can be employed with the weighing scale BCG signal to be used with
the subjects who have difficulty in standing in an upright posture.
One important limitation of this work was the homogeneous nature of the pool
of subjects selected for data collection. Future studies should focus on the inclusion
of people with cardiovascular problems to better differentiate the posture related
features from the physiological changes present in the BCG signal.
5.4 Effect of Posture on Wearable BCG
Wearable BCG, which includes local chest vibrations caused by the beating heart,
can be easily measured with wearable accelerometers. Prior work [43] has shown
that the cardiogenic vibrations measured from wearable sensors comprise multiple
physiological origins. The SCG signals from a tri-axial accelerometer, placed at the
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Figure 19: Experimental setup and processing steps.
produced by valve closure. Thus the signal from an accelerometer can be used to
derive information about various mechanical events taking place in the heart—closing
of mitral, tricuspid, aortic and pulmonary valves—and also regarding hemodynamics.
When a tri-axial accelerometer is attached to various locations on the chest, the
three components of acceleration from the accelerometer can contain a mixture of
these vibrations.
Even though the wearable BCG signal is extremely sensitive to motion artifacts,
change in posture can also affect the measured signal and parameters estimated from
it. In this small study, we extend the work on posture induced distortion in the
weighing scale BCG signal to wearable BCG and analyze the effect of three standing
postures on the measured accelerometer signals.
5.4.1 Protocol & Experimental Setup
A small study was designed to examine the effects of postural and body position
changes on SCG signals, with a particular focus on the ability to accurately extract
STI features from the waveforms. The SCG signals were measured simultaneously
for a set of 9 subjects with ICG and ECG reference measurements (see Fig. 19).
The accelerometer for sensing SCG was placed on the sternum of each subject. Each
subject was asked to stand in three different postures denoted by Pi: standing upright
as in previous study with weighing scale BCG [36, 42], and slouching forward at two
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different angles θ between the tangent to the thoracic spine (the tangent to the T2−T4
vertebrae) with the vertical axis. The three postures are summarized below:
• P1: Upright standing posture i.e., θ ≈ 0◦.
• P2: Slightly slouched standing posture i.e., θ = 20 ∼ 40◦.
• P3: Heavily slouched standing posture i.e., θ = 40◦ ∼ 60◦
Data were collected from 9 subjects (27± 4.2 years, 166± 20.8 lbs, 177± 7.7 cm
height). In all postures, each subject was asked to breathe normally in a resting state
for 40 - 60 seconds. The values of angle θ in the measured data for all subjects were
θ = 35◦ ± 3◦ for P2 and θ = 52◦ ± 4.5◦ for P3.
5.4.2 Hardware Design & Data Processing
The ECG and ICG signals were measured using the BN-EL50 and BN-NICO wireless
measurement modules (BIOPAC Systems, Inc., Goleta, CA), then transmitted wire-
lessly to the data acquisition system (MP150WSW, BIOPAC Systems, Inc., Goleta,
CA) for subsequent digitization at 1 kHz. The SCG signal was measured using a
small tri-axial accelerometer (356A32, PCB Piezotronics, Depew, NY) used in previ-
ous studies [44]. The acquired signals were sampled at frequency fs of 1 kHz.
The ICG and ECG signals were filtered with FIR filters (Kaiser window, pass band
cut-off frequencies: 0.8 - 35 Hz and 2.5 - 40 Hz). For the tri-axial accelerometer, the
acceleration was measured along three axes as shown in Fig. 19. The three axes
were: (1) the axis perpendicular to chest surface called dorso-ventral (D-V) direction,
(2) the longitudinal axis along the surface of the body called head-to-foot (H-F)
direction, and (3) the lateral axis called the right-to-left (R-L) direction. The D-V
component was denoted by SCGD-V and H-F component was denoted by SCGH-F.
Both these components were band-pass filtered separately (FIR, Kaiser window, cut-
off frequencies: 0.8 - 20 Hz for H-F and 0.8 - 40 Hz for D-V) as shown in Fig. 19.
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The reason for choosing higher cut-off frequencies for the D-V signals as compared to
H-F component was the presence of high-frequency vibrations in the former due to
heart valves. The R-L signals were not analyzed in this study. Once the measured
signals were filtered, the R-peaks in the ECG signal of each subject in every posture
were detected with a simple QRS detection algorithm. These peaks were used as
reference points for segmenting the ICG, and H-F and D-V components of SCG
signals in the corresponding posture for that subject; i.e., the signal traces in ECG
R-peaks+600ms, referred to as heartbeats or frames. Since the PEP period is different
during the exhalation and inhalation phases of respiration, the PEP intervals were
estimated for individual ICG beats. The mean µ and standard deviation σ of PEP
values were calculated and the ICG beats were divided into three bins as shown in
Fig. 20 (a): (1) ICG heartbeats with PEP values within µ± 0.25σ were assigned to
Bin 1 (2) ICG heartbeats with PEP values greater than µ + 0.25σ were assigned to
Bin 2, and (3) ICG heartbeats with PEP values less than µ− 0.25σ were assigned to
Bin 3. The SCGD-V and SCGH-F heartbeats corresponding to the ICG heartbeats of
Bin 1 were also labeled as Bin 1 beats while those corresponding to Bin 2 and Bin 3
ICG heartbeats were labeled accordingly. Thus, rather than obtaining one ensemble
or collection of ICG, SCGD-V and SCGH-F heartbeats, three ensembles (bins) for each
of these were obtained according to PEP values. The ICG, SCGD-V and SCGH-F
heartbeats in each bin were then averaged to obtain the respective ensemble averaged
traces. Hence, three ensemble averaged heartbeats for ICG, SCGD-V and SCGH-F
were obtained for each subject in every posture as shown in Fig. 20 (b).
5.4.3 Feature Extraction from ICG & SCG
Features were extracted from the ensemble averaged traces of ICG, SCGD-V and
SCGH-F signals for all subjects in each posture. The following subsections will explain














Figure 20: (a) The division of heartbeats into three bins based on mean and standard
deviation of PEP values from individual ICG heartbeats. (b) Extraction of features
from the ICG heartbeats and different components of sternal acceleration.
5.4.3.1 Features from ICG
The features extracted from the ICG signal included the PEP and LVET. The point
of maximum acceleration before the global peak in the ICG frame was detected by
filtering the ICG heartbeat twice with a Savitzky-Golay differentiator filter. The
highest peak in the differentiated signal was selected as the B-point and PEP esti-
mated was denoted by PEPICG. The X-point was detected as the mimima after the
global peak in the heartbeat as shown in Fig. 20 (b). The difference between B and
X points was estimated as LVET and denoted by LVETICG.
5.4.3.2 Feature from SCGD-V
The most common methods for derivation of features from accelerometer data involve
detection of peaks in the SCG traces [3]. These include the location of peaks cor-
responding to AO and AC events on the dorso-ventral SCG frames [43, 98] and the
J-peak on the estimated BCG signal from H-F acceleration [13].
Accordingly, the features extracted from each ensemble averaged SCGD-V frame
were the points corresponding to the AO and AC events. The AO-point was detected
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as the positive peak that immediately followed the lowest negative peak in the first
200ms portion of the SCGD-V frame. The time between the R-peak of ECG and AO-
point gave an estimate of the PEP interval and was denoted by PEPD-V. In order
to detect the location of the AC-point, the maximas and minimas in the SCGD-V
heartbeat were detected. The upper and lower envelopes, Eu and El, of the SCGD-V
frame were estimated by cubic interpolation of the maximas and minimas. The
envelope difference signal was then obtained as Ed = Eu − El. The highest peak in
E2d , located after the first 200ms portion, was detected and 150ms portion of SCGD-V
frame on both sides of the peak was extracted. The maxima that preceded the lowest
minima in the extracted portion of SCGD-V was chosen as the AC-point. The LVET
was then estimated as LVETD-V = AC - AO (see Fig. 20 (b)).
5.4.3.3 Features from SCGH-F
The H-F ensemble averaged acceleration traces were converted into displacement
signals by integrating each trace twice using the trapezoidal rule [100]. Every trace
was high-pass filtered before each integration step and also after the last integration
step to remove the DC offset as in previous studies [103, 104]. The displacement
trace thus obtained was the equivalent estimated BCG trace for the H-F acceleration
signal. Let each estimated displacement trace be denoted by B̂CGH-F i.e. B̂CGH-F =∫∫
SCGH-F. The method of detecting the J-peak in the trace was similar to the method
used in previous studies involving weighing scale BCG [28]. The J-peak was detected
as the highest positive peak in the first 300ms portion. The time interval between
ECG R-peak and the estimated J-peak formed the R-J interval denoted by R-JH-F.
5.4.4 Results
5.4.4.1 Correlation Results between ICG and SCG Parameters
The heartbeats / frames were extracted for every subject in each of the three stand-
ing postures from the ICG and accelerometer signals and features were extracted
61
𝑟 = 0.82 𝑟 = 0.48 
𝑟 = 0.74 
𝑟 = 0.73 
𝑟 = 0.2 
𝑟 = 0.3 
(a) (b) 
(d) (e) (f) 
𝑃1  𝑃3 𝑃2  
(c) 
𝑟 = 0.62 
𝑟 = 0.61 
𝑟 = 0.61 
Figure 21: Correlation results: (a) LVETD-V vs LVETICG for P1 (b) PEPD-V vs
PEPICG for P1 (c) R-JH-F vs PEPICG for P1 (d) LVETD-V vs LVETICG for P2 and P3
(e) PEPD-V vs PEPICG for P2 and P3 (f) R-JH-F vs PEPICG for P2 and P3.
from the ensemble averaged traces of ICG, SCGD-V and B̂CGH-F. The correlation
coefficients were calculated using linear regression analysis between LVETD-V and
LVETICG, PEPD-V and PEPICG, and R-JH-F and PEPICG in all three postures. The
results for these are shown in Fig. 21. The results show no significant change in
the correlation coefficient value for correlation between LVETD-V and LVETICG in
slouched standing postures P2 and P3 (Fig. 21(d)) compared to correlation coeffi-
cient of good standing posture P1 (Fig. 21(a)). The PEPD-V, however show low
correlation coefficient with PEPICG in all three postures (Fig. 21(b) for P1 and Fig.
21(e) for P2 and P3). This is contrary to results obtained in previous studies [99, 96].
The correlation between R-J intervals from B̂CGH-F and PEP periods from ICG again
show no change across all three postures in Fig. 21(c) & (f). The red data points in
all the correlation plots of Fig. 21 indicate data outliers which were not included in
the correlation analysis.
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Figure 22: Bland-Altman plot for comparison of LVET estimated from SCGD-V and
ICG in different postures.
5.4.4.2 LVET Comparison
LVET was estimated from both ICG and SCGD-V signals. Fig. 22 shows the Bland-
Altman plot for LVET values estimated from SCGD-V and ICG beats for all subjects
in each of the three postures. The plot indicates that LVET from SCGD-V shows
similar level of agreement with LVET from ICG in all three postures. Thus based on
features from SCGD-V beats, there is not much difference in the accelerometer signals
acquired in all three postures.
5.4.5 Discussion & Limitations
The results from this wearable BCG study suggest that for PEP estimation, the
double-integrated H-F component, which approximates a BCG waveform, provides a
better surrogate for PEP than the D-V component. Interestingly, the H-F compo-
nent has largely been ignored for estimation of hemodynamic parameters from the
wearable BCG in the existing literature. These results put an important emphasis
on utilizing this component, which is simultaneously measured with the D-V signals,
in estimation of hemodynamic parameters. On the other hand, the dorso-ventral
component in the acceleration domain provides a robust estimate of LVET in the
three different types of standing postures. Thus as suggested before, the combination
of cardiogenic accelerations in both axes, with a physiology-driven treatment of the
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components, is recommended for future studies aimed at comprehensive systolic time
interval estimation from wearable accelerometers.
An important limitation of this study was the small sample size and the homo-
geneity of subject demographics. Future work should focus on expanding this work
with larger data sets including patients with cardiovascular diseases.
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CHAPTER VI
QUANTIFICATION AND REDUCTION OF MOTION
ARTIFACTS FROM BALLISTOCARDIOGRAM SIGNALS
MEASURED DURING WALKING
6.1 Introduction
A major challenge for wearable BCG, SCG and other mechanical measurements of
cardiovascular function is that high fidelity signals can only be obtained typically
when the user is stationary. Motion artifacts related to walking or other types of
movements can reduce the SNR and even sometimes render the measured signals
unreadable. Hence, most of the studies on wearable BCG using accelerometers report
results only when the subject is at rest [23, 97] and in a good posture. Authors in [73]
demonstrated a method to only extract heart rate from a chest-worn accelerometer.
However, as we have discussed earlier, heart rate is not the only important parameter
describing the cardiac function. It is also important to accurately estimate STIs
during movement.
Analyzing BCG / SCG signals during movement is challenging, since the signals
can be corrupted by motion artifacts associated with footsteps and other external
vibrations coupling into the sensor. Nevertheless, such data during motion is of
paramount importance for understanding how a person’s cardiovascular system re-
sponds to exercise-induced stress; accordingly, the inability to analyze the BCG and
SCG signals during motion is a technical obstacle that, if addressed, can greatly en-
hance the value of wearable BCG and SCG recordings. Rather than only measuring
STIs at rest, the changes in STI associated with particular activities—even simple
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activities such as walking—can potentially provide an earlier indication of cardiovas-
cular disorders, and a more specific tool for monitoring patients outside of clinical
settings. In particular, enabling the estimation of STIs during movement, when the
cardiovascular system is stressed due to the increased demands of the skeletal muscles
and skin for blood flow, can likely provide deeper insight into cardiovascular function
for patients with CVD than measurements at rest alone.
In this chapter, we focus on estimation of STIs from wearable BCG using ac-
celerometers. We first discuss the results of a pilot study that combined estimates
from multiple accelerometers, placed at different locations on the body, during walk-
ing and employed a dynamic time warping (DTW) based algorithm to estimate STIs
during walking at three different speeds. In the later sections, we present a data
driven method for de-noising wearable BCG signals from a small patch that used a
single accelerometer and ECG sensor. We also discuss a simple method for improving
the time resolution of estimates from the wearable sensor during walking.
6.2 Motion Noise Reduction using Multiple Accelerometers
In this pilot study, we processed simultaneously acquired signals from more than one
accelerometer under the condition of walking at slow to moderate speeds. The objec-
tive of this initial study was to find the best position for placement of accelerometer
on the body and also analyze the recorded signals during walking for feasibility of
designing more complicated algorithms (discussed later in section 6.3) for removal of
motion artifacts. Hence, multiple accelerometers were placed at different locations
on the body in this initial work. The features of interest in the accelerometer signals
were detected in the resting phase and then these features were tracked during walk-
ing phases using a novel algorithm involving DTW pattern matching technique. We
also demonstrated that fusion of data from more than one accelerometer could pro-
vide robust estimate of STIs and compared these against the corresponding reference
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standard ICG estimates using correlation and linear regression analysis.
6.2.1 Protocol
The data for the pilot study were collected from 4 subjects (demographics: 27 ± 5.3
years, 171 ± 10.3 cm height, 170 ± 22.7 lbs). Each subject was asked to stand in a
resting state for 1 minute and then walk on a treadmill for 3 minutes at three different
speeds: 0.44 m/s during the first minute and then increased to 0.89 m/s and 1.34 m/s
in the second and third minute as shown in Fig. 23 (a). Five accelerometers were
placed on the body at various locations as shown in Fig. 23 (b). The specific body
locations for placement of accelerometers in this study as shown in Fig. 23 (b) were
chosen in consonance with the existing literature. Most of the prior work on wearable
BCG using one of the five positions used in this study. The H-F data was analyzed
for all 5 accelerometers since it contained the BCG component while the D-V data
was analyzed only for the accelerometers placed on the chest area (sternum, neck and
clavicle) due to presence of vibrations caused by closure of semi-lunar valves. The
protocol was repeated twice on each subject to generate two sets of data due to only
three accelerometers being available for the measurements. Data from the arm, neck
and sternum positions were recorded in the first set while clavicle and ear data were
collected in the next set. Each subject was given 10-15 minutes to relax between
the two sets of data. The ECG and ICG data were also collected to assist in the
processing of the BCG data and also for comparison of results.
6.2.2 Hardware Design & Data Processing
The ECG and ICG signals were measured using the BNEL50 and BN-NICO wireless
measurement modules (BIOPAC Systems, Inc., Goleta, CA) while small tri-axial
accelerometers (356A32, PCB Piezotronics, Depew, NY) were used to measure the
body vibrations. The acquired signals were sampled at 2 kHz.











































Walking at 0.44 m/s, 0.89 m/s and 1.34 m/s
1 min
rest
Figure 23: (a) Block diagram of the setup. Data were collected in resting and walking
states. (b) Position of accelerometers on the body.
were band-pass filtered using FIR filters (Kaiser window, cut-off frequencies: 0.8 -
40 Hz for the ECG, 0.8 - 35 Hz for the ICG and D-V, and 0.8 - 20 Hz for the H-
F). The R-peaks in the filtered ECG signal were detected and the minimum R-R
interval was calculated for each subject. With R-peaks as reference markers and
R-R interval as the frame length, the ICG and accelerometer data were segmented
into individual frames called heartbeats and ensemble averaged to reduce noise [93],
as shown in Fig. 23 (a). All the heartbeats in the resting state for each subject
were ensemble averaged to give one trace while 15-second ensemble size was used for
0.44 m/s walking and a 30-second ensemble size for higher speeds. A larger ensemble
size was chosen for 0.89 m/s and 1.34 m/s walking speeds to reduce noise. The H-F
acceleration heartbeats were converted to the corresponding displacement traces by
integration twice with high pass filtering (FIR, Kaiser window, cut-off: 6Hz) before
and after each integration step to remove the constant terms [104]. The displacement



























Head-to-Foot heartbeats Dorso-Ventral heartbeats
Figure 24: (a) Extraction of template ψh from the resting H-F heartbeat and detection
of the feature fψh (τh = τ
′
h = 250ms). ψh is matched to the H-F heartbeat during
walking and the correct J-peak is detected. (b) Extraction of ψo and ψc from the D-V
heartbeat in the resting state and detection of features fψo and fψc . (τo = τ
′
o = 125ms,
τc = 100ms, τ
′
c = 2τc)
6.2.3 BCG Feature Extraction & DTW based Algorithm
As discussed in Sec. 5.4.3, the most common features extracted from the wearable
BCG signals are related to the positions of peaks in the heartbeat. Hence, in this
study, the highest peak located in the first half of the H-F heartbeat was selected
as the J-peak. Similarly, in the D-V component during the resting phase, the peaks
that best corresponded to the opening and closing of aortic valves were chosen as the
AO- and AC-points. However, during walking, the motion artifacts present in each
heartbeat caused the selection of incorrect peaks and led to errors in estimation of
systolic time intervals.
In order to overcome this problem, we employed DTW, which is a time series
alignment algorithm [66, 82]. DTW finds similarities between two time series of
equal or unequal lengths by warping the time axis and finding the optimal match
under some restrictions. It was assumed that the BCG heartbeats did not change
morphologically and were only translated along the time axis during walking. A
portion of the BCG signal in the resting state of each subject was extracted and used
as a known sequence or template ψ. The feature of interest fψ was then detected
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in ψ. In order to detect the same feature from the BCG heartbeats during walking,
DTW was performed between ψ and the motion corrupted heartbeat. The point
on the motion corrupted heartbeat that mapped to fψ in ψ was detected as the
feature. This process is described in Fig. 24 and explained in detail in the following
subsections:
6.2.3.1 Feature Estimation & Tracking in H-F Heartbeats
The first τh ms portion (τh = 250) of the resting H-F ensemble-averaged heartbeat
was extracted as a template, denoted by ψh, as shown in Fig. 24 (a). The highest
peak in ψh was detected as the J-peak. Let this peak be denoted by fψh . For an
ensemble-averaged H-F heartbeat during walking, DTW was performed between its
first τ ′h ms portion (τ
′
h = τh) and ψh. The peak in the walking heartbeat that mapped
to fψh in ψh after the application of DTW was then selected as the J-peak. The R-J
interval was then estimated as the time difference between the detected J-peak and
the ECG R-peak. If more than one point in the walking H-F heartbeat mapped to
fψh due to DTW, then an average of all these points was estimated as the J-peak.
6.2.3.2 Feature Estimation & Tracking in D-V Heartbeats
The D-V heartbeats involved the detection and tracking of two features corresponding
to AO- and AC-points. Hence, two templates needed to be generated from the D-V
heartbeat in the resting state for each subject as shown in Fig. 24 (b).
In order to detect the AO-point, the first τo ms portion (τo = 125) of the D-V
beat was extracted from the D-V heartbeat of each subject in the resting phase.
The portion was first de-trended and then standardized (set to zero mean and unity
variance by subtracting the mean and dividing by standard deviation) to remove any
low frequency noise that was not filtered out by the band-pass filter. The extracted
portion was used as the first template ψo and the lowest minima in it was chosen as the
AO-point denoted by fψo . For the walking phases, the first τ
′
o ms portion (τ
′
o = τo) of
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each D-V heartbeat was de-trended and standardized. DTW was performed between
the extracted portion and ψo and the minima in the extracted portion from the
walking heartbeat that matched to fφo in φo was chosen as the AO-point. Again,
if more than one point mapped to fψo , then average of these was estimated as the
AO-point.
For the detection of AC-point, the upper and lower envelopes of the whole D-
V heartbeat were estimated by cubic interpolation of maximas and minimas. The
envelope difference ED was calculated and the second highest peak in the ED signal
was denoted by pc as shown in Fig. 24 (b). A portion of τc ms (τc = 100), denoted by
ψc, was extracted from the original D-V signal around the position of pc. This portion
was again de-trended and standardized and the lowest minima in it was chosen as





portion around the pc time instant (obtained from the resting state of each subject)
was extracted. The portion was de-trended and standardized. The template φc was
slid along the extracted portion and DTW was performed at each instant to find the
best match. Once the instant of best match was found, the lowest minima in the part
of the extracted portion that mapped to fφc was chosen as the AC-point. LVET was
the time difference between the AC- and AO-points.
6.2.4 Data Fusion from Multiple Accelerometers
The D-V axis data from the neck and sternum accelerometers were used for calculating
the LVET estimates while the H-F data from all accelerometers were used to estimate
the RJ-intervals. The ICG features, which included PEP and LVET, were estimated
using the feature extraction methods described in chapter 4 and 5 (Sec. 4.4 and
5.4.3.1). In order to improve the correlation between the accelerometer and ICG
estimated parameters during walking, data fusion was employed by averaging the
estimates from two or more simultaneously collected accelerometers data.
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Figure 25: (a) Correlation plot between RJ-intervals from arm combined with ster-
num and the PEP from the ICG. (b) Correlation plot between RJ-intervals from ear
combined with clavicle and the PEP from the ICG. (c) Correlation between LVET
from sternum combined with neck and the LVET from the ICG. The red data points
indicate the outliers and were not used in correlation analysis. n is the number of
data points used in correlation. α = β = 1
2
.
6.3 Results & Discussion
Linear regression based correlation analysis was performed between the R-J intervals
from the H-F data for each accelerometer and the corresponding PEP values from
the ICG and also between linear combinations of the RJ-intervals from two or more
accelerometers and the PEP from the ICG. Similarly, LVET estimates from the D-V
data of neck and sternum accelerometers and their combinations were also correlated
with the LVET estimates from the ICG. The best correlation results are shown in
Fig. 25. For linear combination, averaging (α = β = 1
2
) provided the best results
for two accelerometers. No significant increase in correlation was observed when
estimates from more than two accelerometers were combined. The correlation plots
indicate that DTW and linear combination of two accelerometer estimates achieve a
correlation value greater than 0.7 (p < 0.01) for both types of systolic intervals.
6.3.1 Discussion & Limitations
The results suggest that combining estimates of the same axes from more than one
accelerometer during physical activity provide a better surrogate for PEP and LVET
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intervals. However, using more than one sensor has some disadvantages as well. It
will lead to an increase in the cost of the overall system. Moreover, if one of the
sensors is not attached properly to the body, the error due to motion artifacts in
one sensor will propagate to the overall estimate. In order to reduce noise caused by
walking, the time period during which the heartbeats were averaged was increased
from 15-seconds to 30-seconds as the speed increased from 0.89 m/s to 1.34 m/s.
However, such a larger ensemble size will not be able to track transient changes in
the cardiovascular parameters. Hence, using better de-noising algorithms to remove
motion noise becomes of paramount importance for wearable BCG to be used during
movement periods. We shall discuss such an algorithm in the following sections.
6.4 Removal of Walking Noise
As discussed in previous section, the walking induced distortion in the wearable BCG
signals can be reduced by using ensemble averaging. However, even for walking at a
very slow speed of 0.44 m/s, an ensemble size of 15-seconds was considered for the
averaging process. This is a large time interval considering the cardiovascular physi-
ology undergoes transient changes during exercise. Hence, for robust and continuous
cardiovascular monitoring, a smaller time duration or number of beats will be ideal
to capture such small changes in the cardiovascular function corresponding to exer-
cise stressors. This will only be possible if a signal or heartbeat de-noising algorithm
processes the BCG heartbeats to remove movement related noise.
In this extension of the pilot study presented in the previous sections, we used a
small wearable patch adhered on the sternum to simultaneously measure ECG and
wearable BCG signals during walking at two different speeds. We focused initially on
walking, since it is the most common form of motion that nearly all people perform
during the day, and is the basis for the commonly-used clinical stress test named the
6-minute walk test [25, 39] for patients with cardiovascular problems. The 6-minute
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walk test has emerged as a non-invasive and inexpensive method for assessment of
submaximal exercise capacity of HF patients [39]. Previous studies have shown that
different parameters obtained from the test, such as walking distance and left ventricle
ejection fraction, can provide prognosis of the disease in HF patients [9, 12]. In
addition to walking at a normal pace, data were also collected from each subject
walking at 1.34 m/s on a treadmill for 5 minutes.
The objectives of this research were: (1) to provide a framework, using data
driven methods such as EMD [41, 78, 105], to reduce motion-artifact corruption in the
wearable BCG signals during walking, (2) to compare the performance of the wearable
BCG with a state-of-the-art, commercially available ICG sensor for estimation of STIs
during walking, and (3) to provide a method to objectively determine the minimum
number of heartbeats before an accurate estimate of STIs can be generated using
different techniques for feature detection. This work focused on methods that can be
used with wearable BCG signals, but can also be extended to other sensing modalities
such as ICG as well for de-noising signals during walking and, concordantly, assessing
cardiovascular and respiratory health parameters during movement.
6.4.1 Protocol
Data were collected from 10 young, healthy subjects (Gender: 4 males and 6 females,
Age: 24.9±4.3 years, Weight: 65.8±12.8 kg and Height: 1.68±0.10 m) under a pro-
tocol approved by the IRB at the Georgia Institute of Technology. Two sets of data
were collected from each subject. In the first set, each subject was asked to stand
in a resting state for 1 minute and then walk for 6 minutes at his / her normal pace
followed by 2 minutes of rest (recovery period). In the second set, 1 minute of initial
rest was followed by 5 minutes of walking at 1.34 m/s on a treadmill and subsequent
recovery for 1-2 minutes. The objective of collecting two sets from each subject was



























































































Figure 26: (a) The wearable patch that houses ECG and accelerometer sensors. Three
adhesive electrodes are used with the device. (b) The inside assembly of the wearable
patch houses a Micro-SD card on which the data is recorded. (c) The wearable patch
attached to the sternum with three adhesive electrodes. (d) Block diagram of the
setup. Two sets of data, which comprised of walking at normal speed (the speed at
which each subject usually walked) and walking at 1.34 m/s on the treadmill, were
collected from each subject.
of walking, and (2) controlled (treadmill) environment at a higher and uniform speed
for all subjects. Each subject was given 10-15 minutes of relaxation time between the
two sets of data.
6.4.2 Hardware & Data Processing
In both sets of data, the ECG and acceleration signals were collected with a novel
wearable patch as shown in Fig. 26 (a - c) [27]. Along with the ECG and BCG signals
from the wearable patch, ECG and ICG signals were also simultaneously measured
using the BNEL50 and BN-NICO wireless measurement modules (BIOPAC Systems,
Inc., Goleta, CA) to provide a reference gold-standard for the assessment of PEP
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and LVET. The two ECG signals, from the wearable patch and Biopac, were used to
synchronize data from Biopac and wearable sensor. This was done by tapping both
the sensors before and after the start of measurements for both types of walking, and
performing re-sampling in post-processing accordingly. All the signals from both the
custom wearable patch and Biopac sensors were sampled at 1 kHz.
Once the signals from the sensors were aligned using the tapping artifacts intro-
duced at the beginning and end of each data recording, the initial data processing
steps included band-pass filtering of the ECG, ICG and accelerometer signals using
FIR filters (Kaiser window, cut-off frequencies: 0.8 - 40 Hz for the ECG, and, 0.8 -
35 Hz for the ICG and D-V component of acceleration signals). The ECG R-peaks
in the data from the custom patch and Biopac systems were detected using a simple
thresholding algorithm and manually validated to correct for errors. With R-peaks
as fiduciary points, R-peak+win ms frames, where win was the frame size, were ex-
tracted from the accelerometer and ICG sensors. The value of win was estimated
as the minumum R-R interval in the portion of the ECG signal under consideration.
Thus, the overall recording from each measurement modality was segmented into in-
dividual frames or heartbeats. Note that the accelerometer signals from the wearable
device were segmented using the R-peaks of the ECG from the wearable patch while
the ICG signals were segmented using the R-peaks from the Biopac wireless system
as shown in Fig. 26 (d). The set or subset of heartbeats or frames thus obtained
were then averaged to obtain ensemble-averaged traces, based on time intervals or
the number of heartbeats to reduce noise in the individual heartbeats [93].
6.4.3 Signal De-Noising using EMD
EMD, an analytical and adaptive method, involves breaking down or decomposing
a signal into components, and was developed by Huang et. al in 1998 for analysis
of non-stationary signals [41]. The components which are obtained after EMD are
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specific only to the signal from which they are generated. Specifically, EMD decom-
poses a non-stationary signal into a set of amplitude modulated (AM) and frequency
modulated (FM) tones [78, 31], and these generated components are called intrinsic
mode functions (imfs). The algorithm for obtaining the imfs from the given signal x
is given below [78]:
1. Extract the local maximas and minimas in the signal x.
2. Form the upper eu and lower el envelopes of the signal from interpolation of
maximas and minimas, respectively.
3. Estimate the mean of the two envelopes, i.e., em = (eu + el)/2.
4. Subtract em from x, i.e., h = x− em.
5. Repeat steps 1-4 on h, i.e., x = h.
The above steps (1–4) are called the sifting process and are repeated until h
becomes a zero-mean signal or until some stopping criteria. Once the sifting process is
completed, the signal h yields the first intrinsic mode function (imf ). Let the first imf
be denoted by I1. This imf is subtracted from x to obtain the residue r1 and the steps
(1–5) are repeated on r1 to obtain the second intrinsic mode function. The process
of generating imfs can be stopped if the residue becomes a monotone from which no
further imfs can be generated. Thus, the signal can be decomposed into finite number
of components and can be reconstructed using the equation x =
∑n
i Ii + ri.
In this study, EMD was used to decompose the ensemble-averaged D-V heartbeat
during the walking phase into imfs as shown in Fig. 27 (a). Each ensemble-averaged
walking heartbeat produced 4 or 5 imfs. However, as shown in Fig. 27 (a), only the
first imf closely resembled the resting state D-V heartbeat and thus was used for
further analysis and feature extraction.
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In order to assess the improvement in signal quality before and after the appli-
cation of EMD, DTW was employed to find structural likeness between the walking
heartbeats and resting heartbeat for each subject. DTW, as explained in the previous
section, is a time series alignment method used to find similarities between two time
series [82]. The D-V heartbeats in the resting portion of each subject’s data were
ensemble averaged to obtain an ensemble-averaged resting heartbeat. The walking
heartbeats were divided into 15-second ensembles to obtain ensemble-averaged. The
length of each ensemble-averaged walking heartbeat and resting heartbeat were made
equal by clipping the later portion of the larger heartbeat. The warping distance
between each walking heartbeat and resting heartbeat was calculated and normalized
by the total number of samples present in both heartbeats. Let this normalized warp-
ing distance be denoted by dα. The normalized warping distance was also calculated
between walking heartbeat, after the application of EMD, and the resting heartbeat
and was denoted by dβ. The process was repeated for all subjects and for both user-
specific and 1.34 m/s data sets. The mean and standard deviation was calculated for
dα and dβ for all subjects and for both data sets.
6.4.4 Dorso-Ventral Feature Detection and Tracking
The typical method of feature detection from the D-V acceleration data involves
detection of maximas or minimas in the D-V heartbeat [43]. Since the D-V heartbeats
contain information about both the opening and closure of heart valves, the first half
of the heartbeat was used to find the AO-point while the second half was used to find
the AC-point. In this study, features or points corresponding to AO- and AC-points
were detected from the heartbeats in the resting state for each subject and these
features were tracked during the walking and recovery phases. The methods used for
detecting the AO- and AC- points are described in the next subsections.
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6.4.4.1 AO Feature
For the AO-point, the maximum or minimum with the highest absolute magnitude
in the first 150ms of the heartbeat (as expected for aortic valve opening based on the
physiology) was selected as a feature and denoted by fa (see Fig. 27 (b). Note that
we shall refer to the selected feature (maximum or minimum) as a peak in the rest
of this chapter. The peak from this first segment was defined by two attributes that
will be used as described below for identifying similar peaks in the motion-artifact
corrupted signals acquired during walking: (1) its position in the frame denoted by
pa, i.e., the position of maximum or minimum which ever one was chosen on the basis
of absolute magnitude, and (2) the sign of the maximum or minimum. A ‘+’ sign
was used if the selected peak was a maximum while a ‘−’ sign was used if a minimum
was selected as the peak. The time difference between fa and the ECG R-peak was
estimated as the PEP.
In the walking (after the application of EMD algorithm) and the exercise recovery
heartbeats, the AO-point was detected by tracking the peak selected initially from
the resting heartbeat. Specifically, we searched for a peak with same sign as fa and
in a window of wa (ms) around the position pa of fa as shown in Fig. 27 (b). The
peak which was closest to pa was chosen as the desired AO-point, denoted by f
′
a in
the walking and recovery heartbeats. In case two peaks were found closer to fa in
wa, the preference was given to the peak on the left, i.e., the peak whose position was
less than pa was chosen as the AO-point. The reason for this was that a decrease in
contractility (or, in other words, an increase in PEP) is very unlikely during exercise,
and thus setting the earlier peak as the preferred selection is more physiologically
sound.
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Empirical mode decomposition (EMD)
















Figure 27: (a) De-noising of the D-V heartbeat during walking using EMD algorithm.
Four intrinsic mode functions were generated after the application of EMD. The first
intrinsic mode function (I1) was chosen as the de-noised D-V heartbeat for feature
extraction. (b) Extraction of features from the resting state D-V heartbeat. The
features were tracked during the heartbeats measured while the subjects were walking.
The values of wa and wc were chosen as 60ms and 100ms for user-specific walking and
100ms and 120ms for 1.34m/s walking.
6.4.4.2 AC Feature
An approach similar to the selection of the AO-point was implemented for the de-
tection of the AC-point. The heartbeat was first divided into two parts according
to the envelope based methods discussed in [46]. The AC-point was detected as
the maximum or minimum with highest absolute magnitude in the second half of the
heartbeat. Then, as for the AO-point, the AC-point, denoted by fc, was characterized
by a peak position and peak sign.
In the walking and recovery heartbeats, the peak with similar sign and closer
to pc was searched for in a window of wc ms around the resting state AC-point.
Again, preference was given to the peak which was less than fc in terms of position,
since systolic ejection is likely to shorten, not lengthen, with increased heart rates
associated with exercise.
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6.4.5 Comparison of ICG and Accelerometer Data
In order to compare the ICG and accelerometer data, the ICG heartbeats from the
Biopac were partitioned into 15-second ensembles and averaged to obtain ensemble-
averaged traces. Since, the data from the Biopac and the wearable patch sensor were
time-synchronized, the D-V heartbeats from the accelerometer were also partitioned
into 15-second portions and averaged to obtain ensemble-averaged acceleration traces.
In order to detect the B-point on the ICG ensemble-averaged heartbeats, the heart-
beats were twice differentiated with a Savitzky-Golay filter [28]. The position of the
global peak in the double-differentiated signal was chosen as the B-point and the time
difference between this peak and the ECG R-peak was estimated as the PEP from
the ICG. The PEP from accelerometer was estimated as the time difference between
the AO point and the ECG R-peak.
6.4.6 Quantitative Determination of Ensemble Size
Based on the ICG and accelerometer comparison, a method was devised to estimate
the minimum ensemble size in terms of number of heartbeats required for the ac-
celerometer data to yield accurate estimation of PEP and LVET intervals. In resting
conditions, ensemble averaging is usually performed by using as many beats as are
available, such that the extraction of features can be as accurate as possible. It is
assumed that the cardiovascular state is relatively static, and thus a single ensemble
average can capture all of the information required for assessing that state. However,
during exercise, the cardiovascular state is changing dynamically, with heart rate,
contractility, and stroke volume typically increasing to meet the increased demands
of the skeletal muscles and skin for blood flow. This presents a major challenge from
a feature extraction standpoint. On one hand, capturing the transient information
associated with these changes—such as the time constant with which PEP decreases
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at a given exercise intensity—can provide deep information regarding cardiovascu-
lar health, and the ability of the cardiovascular system to respond to the stress of
exercise; thus, not using ensemble averaging at all would be ideal as one would ob-
tain beat-by-beat information regarding these transients. On the other hand, motion
artifacts are more significant during exercise and thus the noise and interference in
the data is more substantial; thus, using ensemble averages with a high number of
beats would be ideal as one would provide the maximal reduction of such noise and
interference in the measured signals. We therefore aimed to provide a data-driven
methodology for objectively determining the optimal number of beats that should be
used in ensemble averaging during exercise for BCG signals.
Specifically, the optimum ensemble size for each subject was determined by first
sweeping through overlapping window ensemble sizes composed of different number
of heartbeats. Then, to determine the minimum ensemble size for PEP estimation,
ensemble sizes of 64 to 4 heartbeats were traversed with 25% overlap, i.e., each ensem-
ble contained 25% of heartbeats from the previous ensemble. The objective of using
overlapping ensembles or moving average is to increase the number of estimates in the
analysis. For each ensemble size, PEP was estimated by detecting the AO feature in
the heartbeat obtained after the application of EMD algorithm. Once all the PEP es-
timates were obtained for a certain ensemble size during the walking phase, the mean
(µ) and standard deviation (σ) of PEP estimates was calculated and the data points
beyond µ ± 1.75σ were removed from the estimated set. A third degree polynomial
was then fitted to the remaining estimates to capture the trend in the estimated PEP
values with respect to time, with an order low enough to avoid over-fitting. The time
values were chosen as the mean of time index for the first and last heartbeat in the
ensemble and were denoted by the variable tm.
The distance of each point from the best fit line was estimated and root mean






Figure 28: (a) The PEP estimates from the wearable patch and the Biopac ICG
sensor for one subject during different phases of the 6 minute walk test. The data
was divided into 15-s ensembles for both types of sensors. (b) The mean and standard
deviation of PEP estimated from the accelerometer and ICG sensor for all subjects.
The accelerometer estimates PEP with better accuracy for both types of walking tests
and these are significantly different (p << 0.05) from the ICG estimates.
In order to further remove outliers and improve the polynomial fitting, one data point
was iteratively removed from the estimated PEP estimates and RMSE was derived
for the remaining data points. Hence, one data point for which the RMSE decreased
considerably was excluded from the data set and final RMSE error was calculated
for the remaining points. The process was repeated for different ensemble sizes and
RMSE errors were derived for the PEP estimates for each subject.
A similar method was used to find the optimum ensemble size for LVET estimates
by sweeping through ensemble sizes of 80 to 32 heartbeats (25% overlapping windows).
After outlier rejection, a third order polynomial was fitted to the LVET estimates from
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the wearable D-V heartbeats, and RMSE error was derived for each subject.
6.4.7 Results
6.4.7.1 EMD based De-noising
The normalized warping distance between the resting heartbeat and walking heart-
beats, before and after the application of EMD, i.e., dα and dβ, was calculated for all
subjects. The warping distance decreased significantly after the walking heartbeats
were de-noised using the EMD algorithm for all subjects. Since, warping distance
indicates the cost of aligning two time series, a lower cost indicates greater similar-
ity. The mean and standard deviation of normalized warping distance for walking at
user-specific speed was 0.58± 0.27 and 0.32± 0.15 before and after the use of EMD
based de-noising method outlined in this chapter. A paired t-test on dα and dβ arrays
for all subjects also showed statistical significance (p << 0.01). A similar analysis
was done for walking at 1.34m/s and estimated mean and standard deviation of dα
and dβ were 0.48± 0.28 and 0.31± 0.17 (p << 0.05), respectively.
6.4.8 ICG vs Accelerometer
The PEP estimates from the ICG and accelerometer sensors are compared in Fig.
28. The PEP values for one subject during the 6-minute walk test, obtained from the
accelerometer using methods discussed in this chapter, are shown in Fig. 28 (a). These
accelerometer estimates show a strong correlation with the corresponding estimates
from the ICG sensor in accordance with existing literature [97]. However, during the
walking period, the ICG-based PEP estimates are not consistent with physiological
expectations due to motion artifacts—for example, there are several data points where
the PEP values fall below 10ms, and there are increasing and decreasing short-term
spurts that are not consistent with what one would expect from the heart of a healthy



























Ne = 16 beats
Figure 29: Determination of minimum ensemble size using the polynomial fitting
approach for one subject. (a) 64 heartbeats. (b) 32 heartbeats. (c) 16 heartbeats.
(d) 4 heartbeats. The data points in blue are outliers. In order to have same y-axis
scale for each plot, the outliers for some plots are not shown in the above figures but
are explained as follows: 2 data points were detected as outliers in (a), 1 data point
as outlier in (b), 2 data points as outliers in (c) but are not shown, and, 5 data points
as outliers in (d) which are not shown. An outlier was detected by removing the data
point which was more than 1.75 standard deviation away from the mean of all data
points.
used as a gold standard for assessing the BCG estimates during walking. The de-
noised D-V heartbeats from the accelerometer, on the other hand, not only show a
decreasing trend in the PEP as with the ICG during walking, but also provide precise
and accurate estimates that are more in line with physiological expectations during
the walking phase. This observation can be extended to the complete pool of subjects
in this study as shown in Fig. 28 (b), where the standard deviation in relative changes
in PEP at user-defined and 1.34 m/s walking speeds were significantly lower for the
accelerometer as compared to the ICG based measurements.
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Table 3: Results For Minimum Number of Heartbeats Ne in an Ensemble for PEP
and LVET












M 31 200 70 12 36 32 68
F 24 115 63 12 8 32 64
M 24 150 69 8 8 32 32
M 22 172 70 8 12 32 32
M 33 171 73 8 4 36 36
F 19 160 66 20 32 48 72
F 22 115 60 8 48 56 44
F 27 165 64 32 52 36 80
F 24 120 63 12 12 32 44
F 23 140 65 8 24 32 36
µ 25 145.3 66.3 12.8 23.6 36.8 50.8
σ 4 28.3 4.1 7.7 17.5 8.4 18.3
6.4.8.1 Minimum Ensemble Size Analysis
The results for the minimum ensemble size methodology for one representative subject
during the 6-minute walking phase are illustrated in Fig. 29. The minimum number
of heartbeats Ne in an ensemble during walking were estimated for each subject by
fitting a third order polynomial on the PEP values with respect to time. The value of
Ne was decreased from 64 to 4 and the error was estimated at each value. However,
Fig. 29 only shows the PEP estimates for 4 different values of Ne. As the number
of heartbeat were decreased from 64 to 32 in Fig. 29 (b), the estimated values follow
a similar trend as in Fig. 29 (a) without any considerable increase in error. Similar
result is obtained as the number of heartbeats is decreased further in the Fig. 29 (c)
and (d).
The results for all subjects are summarized in Table. 3. We chose an RMSE
threshold of 2ms for PEP estimates for both the 6-minute and 5-minute walking tests,
i.e., the lowest number of heartbeats were chosen for each subject as long as these
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provided an RMSE of less than 2ms from the line of best fit (3rd degree polynomial).
In order to determine the number of heartbeats for the LVET, a sweep of heartbeats
from 80 - 32 was done as compared to 64 - 4 heartbeats and also the threshold for
acceptable RMSE was taken as 10ms. The reason is that the LVET requires detection
of AC-point which is prone to more errors than the detection of AO-point due to low
SNR. The table shows that, if an RMSE of 2ms can be tolerated in PEP estimation,
then on average 12 heartbeats are required while the person is walking at normal
pace. Similarly, accurate LVET estimation within a tolerable 10ms RMSE can be
achieved with an ensemble size of 28 heartbeats during normal walking speeds. As
the speed increases, the number of heartbeats for accurate estimation of both the
PEP and LVET also increase.
6.4.9 Discussion & Limitations
The results suggest that the wearable BCG signals processed using our de-noising
and feature extraction techniques can provide improved estimation of systolic intervals
during walking as compared to the commercially available Biopac ICG system. Recent
research has shown that the D-V heartbeats can be used to extract features for
calculating STIs during resting scenarios [97, 99]. However, the major hurdle in
using wearable BCG for continuous monitoring has always been the exclusion of data
during motion periods. The data during these movement periods can not only provide
additional insight into cardiovascular health but also indicate how different stressors
related to exercise affect cardiac function. In fact, to the best of our knowledge, recent
efforts in this area have focused only on heart rate estimation during the movement
periods. Though heart rate provides useful information about the electrical aspects
of cardiovascular health, there is a strong need to also continuously estimate further
parameters related to cardiac function. This chapter outlines a data driven signal
decomposition method for non-stationary signals that can be used to reduce the
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motion artifacts in wearable BCG measurements taken during walking.
The methods described in this chapter achieve a sufficiently fine time resolution
for the PEP and LVET estimates from the acceleration signals to facilitate analyzing
changes in cardiovascular function associated with walking. During stationary peri-
ods, the acquired signals have a high SNR and accurate estimates can be obtained
on beat-by-beat basis. As the signal SNR decreases during walking or non-stationary
periods, the need to perform ensemble averaging becomes unavoidable. The meth-
ods described in this work can readily be leveraged to obtain a minimum number
of heartbeats that must be captured before an accurate and precise estimate, within
some acceptable error thresholds, can be made for the STIs.
The results provided in the previous sections indicate that the number of heart-
beats required for LVET during both self-paced and 1.34 m/s walking are more than
the number of heartbeats for PEP. This is expected as estimation of LVET hinges on
accurate detection of the point of closure of the aortic valve (the AC-point) in the
heartbeat, which is associated with the relatively quiet second heart sound (i.e., quiet
compared to the first heart sound).
The results in Table. 3 also show that the number of heartbeats required for ac-
curate PEP estimates during 1.34 m/s walking are on average twice the number of
heartbeats for self-paced walking (typically at a much slower pace than 1.34 m/s).
One reason for this large difference can be attributed to the fact that treadmill repre-
sents an artificial controlled environment for walking. While walking on the treadmill,
people actively adjust their gait and balance to overcome the mismatch in their nat-
ural pace and the treadmill speed. Such constraints are not present in the natural
walking surfaces such as side-walks and jogging tracks. These inconsistent adjust-
ments during walking on the treadmill add noise to the measured signals. To further
investigate this hypothesis, we collected data for 1.34 m/s walking on a jogging track
from a subject who had already provided data for the results in Table I. The same
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User-specific pace 1.34m/s (treadmill) 1.34m/s (track)
Figure 30: Comparison of minimum ensemble size for the PEP during walking at a
self-determined pace and at 1.34 m/s on treadmill and track for one subject. The
dotted grey line shows a threshold of 2ms RMSE for the PEP estimates. The minimum
number of heartbeats required for the self-determined pace is greater than 8 while
walking at 1.34 m/s in an uncontrolled environment such as a jogging track requires
more than 16 heartbeats in the ensemble.
procedure for minimum ensemble size estimation was repeated and the results are
summarized in Fig. 30. It can be observed that as the number of heartbeats are de-
creased in the ensemble, the error curves for self-paced walking and 1.34 m/s walking
on a track are quite similar to each other while the treadmill walking curve shows
abrupt changes in RMSE. The minimum ensemble size requirements for this subject,
as observed from Fig. 30, are Ne > 12 (self-determined pace), Ne > 16 (1.34 m/s
track) and Ne > 36 (1.34 m/s treadmill).
The perturbations such as walking or light exercises cause small changes to car-
diovascular function of both healthy people and patients with CVDs. These brief
changes can yield great insight into cardiovascular health. The common practice in
existing research to overcome noise present in the signal involves ensemble-averaging
heartbeat frames. The averaging operation, either performed on some specific num-
ber of frames or on frames present in some time interval, results in improved SNR,
but fails to capture transients in the small changes in cardiovascular parameters from
the measured signals. One of the results presented in this chapter shows that the
number of heartbeats required in averaging operation to increase SNR is inversely
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proportional to the speed of walking. Walking at higher speeds requires a greater
number of heartbeats. Hence, it can be concluded that some measure of intensity of
the activity (speed of walking in this instance) can be incorporated into algorithms
for better estimation of parameters. Thus future work should build on the ideas pre-
sented in this chapter and focus on ‘smart ensemble-averaging ’ of heartbeats which is
adaptive in nature and captures necessary changes in the cardiovascular physiology
while maintaining a good SNR in the signal under analysis.
A limitation of this work is the homogeneous nature of the data set which in-
cludes only healthy and young subjects. The next chapter will include subjects with
cardiovascular disorders and also investigate other feature tracking techniques based
on subject specific parameters. Nevertheless, this work delineates novel methods for
accelerometer signal recovery during motion which can form a foundation for these
future studies and readily extended to other measurement modalities as well.
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CHAPTER VII
WEARABLE MONITORING OF LEFT VENTRICULAR
FUNCTION FOR HEART FAILURE SUBJECTS
7.1 Introduction
Heart failure is a progressive disorder in which heart cannot supply sufficient blood
to meet the demands of the tissues and organs in the body [19]. As a result, fluid
tends to accumulate at different locations in the body. In order to treat HF, diuretics
are often used to get rid of excess fluid [6]. However, diuretics are accompanied with
side-effects which include fatigue, dehydration and dizziness [71]. HF patients need
to be monitored continuously and unobtrusively to assess their condition followed by
modification in treatment and medications.
An important test for cardiovascular assessment is physical exercise, which pro-
duces a large burden on the cardiovascular system [14]. During exercise, the blood
flow is directed towards working muscles. This increased blood flow makes the heart
beat faster. It also causes an increase in the blood volume returning to the heart
[80]. With the passage of time, the left ventricle adapt to higher blood volume and
heart rate falls back towards normal value as more blood can be delivered in one
beat. Hence, exercise is an excellent methodology to study the changes in circulatory
system and how it interacts with respiratory and other systems of the body [62].
The 6-minute walk test, discussed in the previous chapter, is one of the most
common exercise based tests to assess the cardiovascular health of people suffering
from HF disease. The test provides parameters such as change in heart rate and
percentage predicted values of the distance walked, which can be used to deduce
important information about the condition of the HF patients.
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The ultimate goal of this work is to develop a non-invasive wearable system for
monitoring HF patients at home that can measure sufficiently rich information to
enable titration of care. While several studies have attempted to use body weight,
bio-impedance, heart rate variability, and other indirect methods for assessing left
ventricular (LV) function at home for this purpose, none of these approaches has been
successful in improving outcomes. The study uses a wearable patch that measures
ECG and BCG signals, and can compute—from the time delay between the peaks of
these signals —an index of myocardial contractility based on the PEP of the heart.
We hypothesized that changes in PEP following an exercise stressor, specifically a
6-minute walk test, would be significantly muted for New York Heart Association
Class IV HF patients as compared to Class I-II patients [16]. Our rationale was that
in advanced HF (Class IV), the heart is less capable of increasing its performance to
meet the increased demand for blood flow during exercise.
7.2 Protocol
A total number of 23 HF subjects (85±18.7 kg, 7 females) were recruited for this
study. This pool was composed of both inpatients and outpatients. There were 9
patients in the Class I-II group, and 12 patients in the Class IV group. All patients
were asked to stand in a resting state for 1 minute for the baseline readings. This was
followed by 6 minutes of walking at normal pace. At the conclusion of the walking
phase, each subject was asked to recover by standing stationary for 5 minutes. The
distance walked by each subject was also recorded for the 6-minute walk test. Two
of the subjects were morbidly obese, a factor which skews the percent predicted
values for the 6-minute walk test; accordingly, these subjects were not included in the
analysis.
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7.3 Hardware & Data Processing
The wearable device used in the study was the same as shown in Fig. 26 (a) of chapter
6. The device measured ECG and wearable BCG signals. All the signals were sampled
at 1 kHz. The ECG, H-F and D-V signals from the wearable BCG were band-pass
filtered (Kaiser window, cut-offs: 0.8 - 40 Hz for ECG, 0.8 - 35 Hz for the D-V
signals). This was followed by ECG R-peak detection and heartbeat segmentation.
All the heartbeats in the resting 1-minute data were ensemble-averaged to obtain one
trace while the post-walking data was averaged using an ensemble size of 16 beats.
The data during the 6 minute walking period was not analyzed in this initial phase of
this study. Also, only the D-V component of the accelerometer data was considered
for this work. A simple algorithm was implemented to reject extremely distorted and
noisy heartbeats from the ensemble averaging process.
7.4 Algorithm for Selective Heartbeat Ensemble Averaging
The objective of ensemble averaging which involves averaging a specific number of
waveform traces or averaging all waveform traces present in a certain time interval is
to reduce the noise present in each individual heartbeat. If the number of waveform
traces / frames is increased, ensemble averaging gives a cleaner averaged trace as
most of the noise is averaged out. However, this comes with a loss of time resolution
as changes present in each waveform tend to average out during the process. Hence,
there is a trade-off between the number of frames and time resolution required for each
application. Increasing the time resolution implies a decrease in number of heartbeats
for averaging operation and results in a noisy averaged signal. One reason for this
noise is the presence of one or more extremely distorted heartbeats in the ensemble
as shown in Fig. 31. In order to reject those heartbeats, following algorithm was
implemented for ensemble averaging of ne heartbeats present in the ensemble:
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Rejecting heartbeats with 𝛾𝑛% datapoints





Figure 31: New method of ensemble averaging that involves rejection of extremely
distorted or noisy heartbeats. The heartbeats which have more than γn % of total
data points beyond one standard deviation above or below the mean trace are rejected.
γn = 40% was chosen for the data set. The cleaner ensemble averaged trace is then
calculated using the remaining heartbeats.
1. Calculate the averaged trace for the ne heartbeats. The data point at a particu-
lar location in the averaged trace is the mean of all data points at that location
from individual traces. Let this averaged trace be denoted by µe.
2. Calculate the standard deviation of each data point in ne heartbeats. Let the
trace formed by sum of mean and standard deviation of each data point be
represented by µe + σe. Similarly, the trace formed by difference between mean
and standard deviation of each data point be represented by µe−σe. These are
shown in Fig. 31.
3. For each individual heartbeat, find the number of data points beyond the µe+σe
and µe − σe regions.
4. If the percentage of data points for any individual heartbeat beyond the specified
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regions is greater than a threshold γn, then reject the heartbeat.
5. Calculate the new ensemble-averaged trace using the remaining heartbeats in
the ensemble.
7.5 Pre- and Post-Walk PEP Comparison
For each subject, we computed the percent changes in PEP following the 6-minute
walk test (normalized to their baseline PEP value at rest), as well as the percent pre-
dicted value of the distance (based on age and subject demographics). The estimation
of these two parameters is explained in the next sub-sections.
7.5.1 PEP Estimation
In order to estimate the PEP, the minima or maxima with the highest absolute value
was detected as the AO-point from the ensemble averaged trace of the heartbeats in
the first minute of baseline readings. The time difference between this feature and the
ECG R-peak was estimated as the PEP in the resting state and denoted by PEPrest.
This AO-point detected from the resting state data for each subject was tracked using
DTW based algorithm (used in Chapter VI) in the post-walk recovery period. For
this study, the first 16 heartbeats immediately following the 6-minute walking period
were considered for the post-walk PEP estimation. Let the PEP estimated from the
ensemble-average of these 16 heartbeats be denoted by PEPpost. The change in PEP
was then calculated as ∆PEP = (PEPpost − PEPrest)/PEPrest.
7.5.2 Percentage Predicted Walking Distance
The distance walked by each subject was measured during the 6-minute walk test. Let
this distance be denoted by dw. Also the distance supposed to be covered during the
6-minute walk test by each subject according to their respective gender, weight and
height statistic was calculated as explained in [26]. The expected distance covered by




























Figure 32: ∆ PEP vs % Predicted Distance for HF subjects. The class IV subjects are
concentrated in the lower right corner of the figure with mean and standard deviation
of −0.11± 0.06 for ∆ PEP and 0.35± 0.11 for the % Predicted Distance. Similarly,
the class I-II subjects are concentrated in the upper left corner of the figure with
mean and standard deviation of −0.26 ± 0.15 for ∆ PEP and 0.78 ± 0.25 for the %
Predicted Distance.
d′w(male) = (7.57×H)− (5.02× A)− (1.76×W )− 309 (12)
d′w(female) = (2.11×H)− (2.29× A)− (5.78×W ) + 667 (13)
where H is the height in centimeters, A is the age in years and W is the weight in
kilograms. The percentage predicted distance was then estimated as the ratio of the
true and calculated distance, i.e., dw/d
′
w.
7.5.3 Analysis & Discussion
The results supported our hypothesis: the changes in PEP were significantly lower for
the Class IV patients as compared to the Class I-II patients (Figure 1 (c), p < 0.05).
As expected, we also found that the difference in percent predicted 6-minute walk
test distance was significant between the two groups of patients, as was the average
distance walked (p < 0.05). We did not find any significant difference in the heart rate
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response in the two groups, supporting the importance of measuring a combination
of electrical and mechanical signals from the heart (i.e., ECG and BCG).
While the 6-minute walk test requires the patients to perform a prescribed activity,
changes in PEP can potentially be observed in response to any natural activity that
patients are performing on their own while wearing the system; this may increase
patient adherence as it will require less involvement, while still providing an indication
of whether a patients condition may be worsening, and whether an exacerbation is
imminent.
7.6 Future Work
The initial results obtained in this study indicate the potential of the wearable BCG
methodology, used in tandem with sub-maximal exercise stressors, for monitoring
heart failure patients at home following discharge. The next step involves a study
with a larger pool of heart failure patients at different stages of the condition, and
examining longitudinal changes in their PEP response to activity. The longitudinal
trends in BCG based parameters can yield important insight into how these features
can be used to track improvement or worsening of the condition in non-clinical set-
tings. This will also lead to design of algorithms which can indicate the need for
re-hospitalization or a clinical visit. Moreover, the daily report from the monitoring
system can be sent to the patient’s physician who can advise changes in medication
or therapy with the changing state of the condition.
97
CHAPTER VIII
CONCLUSION & FUTURE DIRECTIONS
8.1 Conclusions
The work presented in this thesis lays the groundwork for augmenting the care of
patients having respiratory disorders and heart failure. Specifically, algorithms were
developed for extraction of features to detect sleep apnea with an under-the-mattress
IR-UWB radar and a microphone placed on the side-table. Such a non-contact system
can be used in home settings for whole night monitoring. However, in order to
derive statistically significant results, future work would include a study of substantial
size and duration. In cardiovascular disease monitoring, the BCG methodology was
revisited with novel algorithms for improved estimation of STIs to compensate for
posture and movement related artifacts.
The most important study, described in Chapter VI, deals with the removal of
movement induced noise in the measured signals from a wearable accelerometer. Ac-
tivity such as walking makes the wearable BCG signals completely unreadable. This
work provides the basis for how data during the periods of simple exercise, such as
walking, can be used to have a complete and thorough assessment of cardiovascular
function. The device can be calibrated periodically during the stationary periods and
this information can then be used with noise reduction algorithms, such as EMD, for
accurate estimation of STIs during walking. The wearable accelerometer based BCG,
when coupled with proper noise removal algorithm, worked better than the existing
ICG methodology during the walking phases. Moreover, the results in Chapter VI
also indicated that walking speed is inversely proportional to the accuracy and res-
olution of STI estimates from the wearable BCG. Thus, features related to speed of
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walking can be incorporated in the estimation algorithms to adaptively change the
resolution of obtained parameters with speed.
Another important contribution of this work involves the assessment of left ven-
tricular function for HF patients in different stages of the disorder. Chapter VII briefly
discusses the use of wearable BCG to assess the changes in PEP before and after a 6-
minute walk test. The results from the study indicate that changes in PEP measured
from the dorso-ventral axis of the wearable accelerometer are statistically significant
for Class IV HF group as compared to Class I-II patients. This work, combined with
algorithms for quantification and removal of noise from wearable BCG during walk-
ing, can herald the use of BCG methodology for continuous and robust cardiovascular
assessment at home.
New methods for improved estimation of STIs in different standing postures were
also conceived and developed. The BCG signals from weighing scale based sensors
and wearable accelerometer were also analyzed during different postures to determine
features which can be indicative of posture as compared to physiological changes.
These features involve changes in power spectral density of measured signals in higher
frequency bands during non-ideal postures which can potentially be used with posture
detection algorithms.
The methods described in this dissertation, specifically for the BCG based mea-
surements, can be readily extended to other measurement modalities. Moreover,
parameters from different sensors can be combined with the BCG-derived features to
further increase the range of physiological indicators for cardiovascular and respira-
tory assessment.
8.2 Future Directions
Future work in the sleep monitoring aspects of this thesis should focus on including
more sensors to improve the quality of information obtained, increasing the number of
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subjects studied and widening the subject demographics. In the cardiovascular mon-
itoring application of this work, longitudinal data should be collected and analyzed
from heart failure patients both in the hospital and at home; this data, combined with
the intellectual contributions of this dissertation, can potentially lead to predicting
and preventing exacerbations for patients at home, thus improving the quality of care.
Future work should also focus on intelligent algorithms that can change adap-
tively to stationary and activity periods and also incorporate the intensity of the
exercise or activity for accurate estimation of parameters from the wearable sensors.
8.3 Final Remarks
The methods and algorithms developed and discussed in this work could significantly
improve home monitoring of cardiovascular and respiratory diseases, and advance our
understanding of basic physiology by providing a platform for easy and unobtrusive
measurements of important mechanical parameters of physiological function. The
rapidly growing need for inexpensive health care solutions in the developed world
today, coupled with the exploding population and reducing health care resources is
the main motivation behind this work. Many low-cost, miniature and easy-to-use
sensors are available for unobtrusive monitoring at home. However, there are still
gaps and limitations in using these for continuous monitoring and also during different
phases of daily living. This dissertation addresses many of these limitations through
the use of both novel algorithms and measurement modalities that can potentially
improve the accuracy of health parameters measured outside of clinical settings.
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